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ABSTRACT 
The influence of neighborhood socioeconomic disadvantage and social discomfort on high-risk injection 
behavior among people who inject drugs 
Jennifer DeCuir 
 Research on the determinants of injection drug use behavior has traditionally concentrated on 
factors operating at the individual level.  However, more recent studies have found that behaviors 
surrounding injection drug use are shaped, not only by individual-level characteristics, but also by the 
environment in which they occur.  The risk environment paradigm, proposed by Rhodes and colleagues, 
describes how factors exogenous to the individual influence high-risk injection behavior and blood borne 
virus (BBV) transmission among people who inject drugs (PWID).  To date, few elements of the risk 
environment have been evaluated as potential determinants of high-risk injection behavior.  The purpose 
of this dissertation was to study the influence of two elements of the risk environment on unsafe injection 
practices among PWID – neighborhood socioeconomic disadvantage and social discomfort surrounding 
the acquisition of sterile syringes from syringe exchange programs (SEPs) and pharmacies.  To this end, 
a systematic literature review was conducted on the relation between neighborhood context and injection 
drug use behavior.  Research gaps and methodological challenges identified in this review were used to 
design analyses exploring relations among neighborhood disadvantage, social discomfort, and high-risk 
injection behavior.  These analyses were conducted using data collected from 484 PWID enrolled in the 
Pharmacists as Resources Making Links to Community Services (PHARM-Link) study, combined with 
data from the American Community Survey.  Poisson regression with robust error variance was used to 
estimate associations between measures of neighborhood socioeconomic disadvantage and high-risk 
injection behavior.  SEP accessibility and drug-related police activity were evaluated as potential 
modifiers of these relations.  Similar methods were used to estimate associations between measures of 
social discomfort and high-risk injection behavior, including neighborhood socioeconomic disadvantage 
as a potential effect modifier.  The systematic literature review on neighborhood context and injection 
drug use behavior identified few articles pertaining to this relation (n=22).  Selected studies primarily 
investigated the influence of structural aspects of the neighborhood environment on behaviors 
surrounding injection drug use, while aspects of the social environment and potential modifiers of 
 
neighborhood-behavior relations were understudied.  Subsequent quantitative analyses revealed that 
neighborhood socioeconomic disadvantage was associated with safer injection behaviors among PWID.  
Injectors in disadvantaged neighborhoods reported less receptive syringe sharing and less unsterile 
syringe use than their counterparts in relatively better off neighborhoods.  Drug-related police activity 
attenuated associations between neighborhood disadvantage and unsterile syringe use, while the 
direction of associations between neighborhood disadvantage and the use of unsafe syringe sources 
varied with levels of SEP accessibility.  In neighborhoods with high SEP accessibility, neighborhood 
disadvantage was associated with decreased use of unsafe syringe sources, while in neighborhoods with 
low SEP accessibility, neighborhood disadvantage was associated with increased use of unsafe syringe 
sources.  Social discomfort was not associated with high-risk injection behavior, but effect modification 
was detected between neighborhood disadvantage and two items measuring the quality of relationships 
between participants and syringe staff: “Pharmacists care about my health and well-being” and “The staff 
at syringe exchange programs seems to care about my health and well-being.”  In disadvantaged 
neighborhoods, participants who reported positive relationships with syringe staff were less likely to 
engage in receptive syringe sharing.  However, in relatively better off neighborhoods, positive 
relationships with syringe staff were associated with increased receptive syringe sharing.  Overall, the 
results of this dissertation support the validity of the risk environment paradigm in shaping high-risk 
injection behavior among PWID.  Future studies should continue to investigate contextual factors as 
determinants of behavior surrounding injection drug use.  Understanding how aspects of local-area 
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CHAPTER 1: Introduction 
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Injection drug use, HIV, and HCV 
Injection drug use continues to be an important public health problem in the United States.  
According to the National Survey on Drug Use and Health (NSDUH), an estimated 425,000 persons aged 
12 years and older used a needle to inject illicit drugs in 2008.1  People who inject drugs (PWID) are at 
risk of acquiring and transmitting blood-borne viruses (BBVs) through the use of high-risk injection 
behaviors.  They may use contaminated injection equipment obtained from unsafe sources or share 
syringes with serodiscordant PWID, facilitating the spread of infections like HIV, hepatitis B virus (HBV), 
and hepatitis C virus (HCV).2,3  PWID may also reuse their own syringes, increasing their risk of 
endocarditis, abscesses, and cellulitis.4,5 
 Because of the seriousness of their sequelae, HIV and HCV are of special concern among the 
health risks associated with injection drug use.  In the United States, an estimated 8% of new HIV 
infections can be attributed to injection drug use, while an additional 3% are associated with both injection 
drug use and male-to-male sexual contact.6  Approximately 9-12% of PWID in the United States are HIV-
positive.7  While HIV incidence among PWID has decreased dramatically since the early 1990s,8,9 drug 
injection continues to be the main driver of HCV transmission in the United States.10  In 2013, 62% of 
acute HCV cases for which risk factors were reported were due to illicit drug injection.10  A systematic 
review on the global epidemiology of HCV estimated that 70-77% of PWID in the United States are HCV 
antibody positive.11  Additional studies suggest a high incidence of HCV shortly after the initiation of 
injection drug use.  Hagan and colleagues estimated that HCV incidence was 27.6% (16.9%-41.7%) 
among PWID during their first year of drug injection.12 
New York City represents an important microcosm of the drug injecting population in the United 
States.  By the late 1980s, the city had become the epicenter of the nation’s injection drug use and 
HIV/AIDS epidemics.13  Today, it is still home to the largest drug injecting population in the country, with 
an estimated 104,000 PWID residing in the New York, NY metropolitan statistical area.14  Extensive harm 
reduction efforts designed to increase access to sterile syringes among PWID have brought about large 
declines in the proportion of new HIV/AIDS diagnoses attributable to injection drug use.9  In the early 
1990s, as many as 50% of new HIV/AIDS cases occurred among PWID,15 while that proportion was just 
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4.4% in 2012.16  However, HCV remains common among PWID in New York City.  A population-based 
serosurvey conducted in 2004 found that 64.5% of PWID were HCV antibody positive.17 
 
Syringe exchange programs 
While drug treatment is recommended for all PWID, many members of this population face 
barriers to seeking treatment, and therefore, continue to inject.  As a result, the public health community 
has adopted a harm reduction approach to address the negative consequences of injection drug use.  
Federal agencies recommend that PWID use a new, sterile syringe for each injection to limit the risk of 
BBVs and other infections brought about by high-risk injection behaviors, including the use of unsafe 
syringe sources, syringe sharing, and syringe reuse.2,18  Syringe exchange programs (SEPs) have been 
opened in cities across the United States to increase access to sterile syringes among PWID and to 
remove used syringes from circulation.  Many SEPs offer a variety of additional services as well, including 
referrals to drug treatment, HIV testing, TB screening, on-site medical care, and access to food and 
clothing.19,20  As of July 2013, there were more than 200 SEPs operating in 166 cities across the United 
States.21  Fourteen of these programs are located in New York City, where they operate more than 45 
fixed sites and mobile outreach teams.22  
Since the first SEP opened in Amsterdam in 1984, these programs have been evaluated 
extensively in the literature.23-25  Numerous studies suggest that participation in SEPs is associated with 
reduced syringe sharing among PWID.23-25  A recent “review of reviews” on the provision of sterile 
injection equipment to PWID found that 39 of 43 studies on SEP effectiveness detected significant 
reductions in injection risk behavior among PWID who had access to their services.25  Additional studies 
have linked SEP use to decreases in HIV incidence.9,26  Although the evidence linking SEPs to reductions 
in HCV incidence is more tenuous, several reports have documented inverse associations between SEP 
use and HCV infection as well.27-30   
 Despite the evidence supporting the effectiveness of SEPs, their operation remains controversial 
in the United States.  Law enforcement agencies and some community members view the distribution of 
syringes as enabling drug use, which is commonly framed as an illegal and morally unacceptable 
behavior.13  The negative connotation associated with drug use, and drug injection in particular, has 
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created significant barriers to SEP use among PWID.  Injectors often cite police harassment as a barrier 
to obtaining syringes from SEPs, and, with the exception of a brief period between 2009 and 2011, 
Congress has prohibited the federal funding of these programs since 1988.31-33  Community opposition 
and insufficient financial support have limited the number of SEPs operating in the United States and the 
services they provide.13  As a result, many have restricted hours of operation and may be located too far 
from the residences of PWID to provide adequate syringe coverage.   
 
Non-prescription syringes sales from pharmacies 
Given the limitations of SEPs to meet the injection equipment needs of PWID and the importance 
of preventing BBVs, several US states have legalized the sale of syringes from pharmacies without a 
prescription.  Pharmacies are often open for longer hours than SEPs and may be more conveniently 
located for PWID to access.  As a result, they serve as an important alternative syringe source for PWID 
and may reach populations of injectors who do not use SEPs.34  Because the legalization of syringe sales 
is relatively new, few studies have been published on its effectiveness.  At least three studies conducted 
in the United States have documented reductions in syringe sharing after the initiation of pharmacy 
syringe sales;35-37 however, little to no evidence exists with regard to the role that pharmacy-acquired 
syringes may play in the prevention of BBVs.25  
 In New York State, non-prescription pharmacy syringe sales became legal with the 
implementation of the Expanded Syringe Access Program (ESAP) in January 2001.38,39  Under the ESAP 
law, pharmacists, medical providers, and health care facilities that register with the New York State 
Department of Health are permitted to sell or furnish up to 10 syringes at a time to persons 18 years of 
age or older.  Within a year of the program’s initiation, up to 89% of pharmacies in each of New York 
City’s boroughs were selling syringes under the law.40  An evaluation of ESAP conducted in Harlem and 
the Bronx found that the use of syringes known to have been used by another injector, commonly referred 
to as receptive syringe sharing, decreased significantly among PWID after the start of the program, from 
13.4% at the beginning of 2001 to 3.6% in mid-2003.37  Furthermore, logistic regression models from this 
study showed that time since ESAP implementation and having obtained the last used syringe through 
ESAP were associated with decreased receptive syringe sharing at the last injection. 
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The problem: high-risk injection behavior 
Despite the availability of sterile syringes from SEPs and pharmacies in NYC and many other 
parts of the country, PWID continue to face barriers to accessing sterile syringes from safe, legal sources.  
These barriers include restricted hours of SEP operation, distance to SEPs, and police harassment at 
points of sterile syringe access.  As a result of these and other barriers that have yet to be identified, 
PWID engage in high-risk injection behaviors that facilitate the transmission of BBVs (Figure 1.1).  For the 
purposes of this dissertation, the term high-risk injection behavior will refer to injection risk behaviors that 
reflect low sterile syringe access among PWID – for example, the acquisition of syringes from unsafe 
sources, syringe sharing, syringe reuse, and unsterile syringe use.  As mentioned previously, PWID 
continue to practice each of these behaviors despite structural interventions to increase sterile syringe 
access in this population. 
A report summarizing data collected from a sample of PWID between 2006 and 2008 as part of 
the NSDUH illustrates the extent of this problem.1  When PWID were asked where they acquired the 
syringe used at the last injection, more than 65% reported using a safe syringe source: 52.8% had 
purchased the syringe from a pharmacy, while 12.4% had used a SEP.  However, the remaining 34% of 
respondents reported potentially unsafe syringe sources: 11.8% bought the syringe on the street, 0.5% 
used a syringe from a shooting gallery, and 21.9% acquired the syringe from “other” sources.  A shooting 
gallery is a location, often an abandoned building or private residence, where PWID can rent, borrow, or 
purchase syringes for the purpose of injecting drugs.  Shooting galleries and street syringe buys are 
considered unsafe because the injection equipment available in these venues may have previously been 
used by other PWID.  “Other” syringe sources may also be unsafe because they include both potentially 
safe and unsafe syringe sources.  Potentially safe syringe sources in the “other” category include people 
who distribute syringes from SEPs or pharmacies, health care providers, and diabetic friends or relatives.  
Conversely, examples of potentially unsafe syringe sources in the “other” category include friends or 
relatives who either share their used syringes or acquire their syringes from an unspecified source.   
In addition to the use of unsafe syringe sources, receptive syringe sharing, syringe reuse, and 
unsterile syringe use continue to be problematic.  PWID who face barriers accessing sterile syringes from 
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safe sources may accept syringes that have been used by other PWID or reuse syringes they have 
already used in the past.  According to the NSDUH report described above, 51.0% of PWID reused a 
needle they had used before during the last injection episode, while 13.0% used a needle that they knew 
or suspected someone else had used before them.1 
 
The risk environment 
In an effort to curb BBV transmission among PWID, investigators have attempted to identify the 
determinants of high-risk injection behavior.  Although these behaviors are likely influenced by factors 
operating at the level of the individual, empiric literature is emerging to suggest that they are also 
influenced by the environment in which they occur.41-49  Several authors have written conceptual articles 
describing how contextual determinants influence BBV risk,50,51 but the paradigm most often cited is that 
proposed by Rhodes and colleagues in their writings on the risk environment.52-54  The risk environment is 
comprised of factors exogenous to the individual – the space in which physical, social, political, and 
economic influences interact to shape risk behavior and BBV transmission.53  In this paradigm, risk 
factors are conceptualized as operating on multiple levels of influence, ranging from micro- to macro-
scale.  A micro-level influence may function within interpersonal relationships among PWID, while a 
macro-level influence affects large groups of PWID simultaneously.  Examples of factors in the risk 
environment that may affect syringe access behavior include neighborhood socioeconomic disadvantage 
and the social discomfort experienced by PWID in pharmacies and SEPs.  These examples are 
discussed in detail below. 
 
Neighborhood socioeconomic disadvantage and high-risk injection behavior 
Neighborhood socioeconomic disadvantage has been linked to a variety of health outcomes and 
behaviors.55  Examples include all-cause mortality, low birth weight, systolic blood pressure, and 
smoking.55  Although numerous studies have demonstrated the importance of this construct in shaping 
health outcomes, its influence on risky injection practices has yet to be thoroughly explored.   
Existing evidence suggests a number of pathways through which neighborhood disadvantage 
may increase high-risk injection behavior (Figure 1.1).  For example, disadvantaged neighborhoods may 
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have larger populations of PWID, which may lead injectors to form larger, denser injection networks.  Both 
network size and network density have been shown to be associated with syringe sharing,56 potentially 
increasing the likelihood of high-risk injection behavior in poor neighborhoods.  Disadvantaged 
neighborhoods may also have a greater availability of syringes from unsafe sources, such as syringe 
dealers and public spaces dedicated to injection drug use.  PWID in these neighborhoods may, therefore, 
be more likely to use unsafe syringe sources in comparison to those in less disadvantaged 
neighborhoods.  A third pathway through which neighborhood disadvantage may influence high-risk 
injection behavior is through neighborhood disorder.  Neighborhood disorder can be defined as a series 
of physical and social characteristics that are indicative of neighborhood decay.  Examples include graffiti, 
vacant housing, litter on the street, loitering teens, and the prevalence of burglary, drug selling, and 
assault.  Neighborhoods with poor socioeconomic indicators may exhibit higher levels of disorder, which 
may impose psychological distress on PWID.57-59  This psychological distress may lead PWID to engage 
in riskier injection practices.  Latkin and colleagues found evidence to support this hypothesis among a 
sample of 701 PWID in Baltimore, Maryland.41  Structural equation models suggested that psychological 
distress was higher among PWID in more disordered neighborhoods, which led to greater sharing and 
use of unsterile injection equipment. 
Although the relation between neighborhood disadvantage and high-risk injection behavior has 
yet to be thoroughly investigated, at least one US study has considered the influence of neighborhood-
level socioeconomic characteristics on receptive syringe sharing.  In a sample of 4,956 PWID recruited in 
the San Francisco Bay area, Bluthenthal et al. found no association between census tract-level 
socioeconomic indicators and receptive syringe sharing in the past six months.42  While the authors of this 
study concluded that measures of neighborhood socioeconomic context may be poor predictors of risk 
behavior among PWID, they also acknowledged that the results of their analyses may have been biased 
by random measurement error.  For approximately one-third of the study sample, there was some 
ambiguity in assigning participants to their corresponding census tracts.  As a result, non-differential 
misclassification may have underestimated relations between neighborhood socioeconomic indicators 
and receptive syringe sharing, potentially rendering null findings despite the existence of underlying 
associations.     
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The study of area-level and spatial predictors of injection drug use behavior is an emerging field, 
and this literature has yet to be reviewed.  Although neighborhood socioeconomic context has been 
linked to a variety of health conditions, the influence of this construct on high-risk injection behavior 
remains unknown.  With sterile syringe equipment now available to PWID through both SEPs and 
pharmacies in several US states, additional research is needed to evaluate how neighborhood 
disadvantage may influence risky injection behaviors in the setting of increased syringe availability.  
Clarifying this relation may lead to more effective targeting of harm reduction interventions geared toward 
the prevention of BBVs among PWID. 
 
Neighborhood socioeconomic disadvantage, syringe exchange program accessibility, drug-
related police activity, and high-risk injection behavior 
As discussed above, the risk environment paradigm emphasizes not only the influence of 
contextual factors on BBV transmission, but also the interplay of these factors in shaping outcomes 
among PWID.  Therefore, further investigation of the relation between neighborhood disadvantage and 
high-risk injection behavior should study, not only the association between these constructs, but also how 
these relations are modified by other factors in the risk environment.  A review of current evidence reveals 
two potential modifiers of relations between neighborhood disadvantage and high-risk injection behavior: 
SEP accessibility and drug-related police activity (Figure 1.1). 
Extensive research has shown that SEP participation is inversely associated with high-risk 
injection behavior; however, further studies suggest that SEP accessibility is inversely associated with 
this outcome as well.44-46,60  Among a sample of 805 PWID in New York City, Rockwell and colleagues 
found that participants residing within a 10-minute walk of a SEP were more likely to report SEP use and 
less likely to report receptive syringe sharing than participants who lived farther away.44  Similarly, among 
a sample of 2576 PWID in Glasgow, Scotland, participants who resided within one mile of a SEP were 
less likely to report receptive syringe sharing in the six months prior to interview.45 
While SEP accessibility appears to decrease the likelihood of high-risk injection behavior, drug-
related police activity has been established as a barrier to syringe access.  Qualitative studies conducted 
among samples of PWID around the world reveal a widespread fear of police encounters.61-66  Depending 
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on local drug laws, PWID stopped by police may be subjected to violence, have their syringes 
confiscated, or be arrested for possession of drugs and injection paraphernalia.  Such negative 
experiences with law enforcement may discourage PWID from carrying sterile syringes and from 
accessing syringes from pharmacies and SEPs.66-69  In a study conducted in New York City, Beletsky and 
colleagues found that PWID who reported police stops were less likely to use SEPs consistently.70  
Similarly, studies in Oakland, California; Philadelphia, Pennsylvania; Vancouver, Canada; and a suburb of 
Melbourne, Australia found that police crackdowns were linked to decreased SEP attendance and unsafe 
injecting practices.69,71-73  PWID who refrain from carrying sterile syringes, avoid safe syringe sources, or 
have syringes confiscated by police may be without sterile injecting equipment when the opportunity to 
inject arises.  Consequently, they may be more likely to engage in high-risk injection behaviors, including 
the use of unsafe syringe sources, receptive syringe sharing, and syringe reuse.66,67,72  Two studies 
conducted in California provide evidence to support this hypothesis.  In both analyses, concern about 




Figure 1.1. Model of the influence of neighborhood socioeconomic disadvantage on high-risk injection 















Social discomfort and high-risk injection behavior 
In addition to neighborhood disadvantage, many social elements of the risk environment remain 
understudied as determinants of high-risk injection behavior.  One example is the social discomfort 
experienced by PWID when accessing syringes from pharmacies and SEPs (Figure 1.2).  Numerous 
qualitative studies have shown that PWID feel uncomfortable entering pharmacies to purchase syringes, 
even in areas where such sales have been legalized.61,62,76-78  Many fear being labeled as “injection drug 
users” by pharmacy staff and suffering poor treatment as a result.61,62,76-80  One woman described her 
experience with pharmacy staff as follows: “…they don’t smile at you or nothing, know what I mean,…if 
you’re in there with other people and that, customers, you don’t know what they are going to say and you 
feel uncomfortable.”78  Experiences like these have led PWID to cite unfriendly attitudes and judgmental 
treatment by pharmacy staff as obstacles to pharmacy syringe purchases.62,77,81  Pharmacists may refuse 
to sell syringes to PWID or question them about the intended use of syringes.61,76,79,82  In addition, PWID 
may be reluctant to ask pharmacists for syringes out of fear that pharmacy staff and/or other shoppers 
may become aware of their drug use, and inform other members of the community.76,78,81 
Although some injectors are hesitant to enter SEPs for fear of publicly identifying themselves as 
PWID,65,78,83 many seem to feel more comfortable entering SEPs than pharmacies.61,76,84  In qualitative 
interviews, some refer to SEPs as safe havens in which they can acquire syringes and access needed 
services in a nonjudgmental environment.76,84  In contrast to pharmacy staff, SEP staff have been 
described as helpful, understanding, and supportive.64,76,78,83,84 
 Several investigators have attributed the social discomfort experienced by PWID in pharmacies 
and SEPs to the stigma associated with injection drug use.76-78  According to Goffman, stigma is “an 
attribute that is deeply discrediting” and one that reduces the individual “from a whole and usual person to 
a tainted discounted one.”85  Observers have described at least three types of stigma that stigmatized 
individuals may encounter – enacted stigma, internalized stigma, and perceived stigma.  Enacted stigma 
is the extent to which individuals experience discrimination from others in reaction to their stigmatized 
attribute.86  Internalized stigma is the extent to which individuals adopt negative beliefs about their 
stigmatized attribute and apply them to the self.87  Perceived stigma is the extent to which individuals 
expect to experience discrimination from others in reaction to their stigmatized attribute.88  Negative 
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attitudes toward drug use and drug injection are pervasive in today’s society, and as a result, PWID are 
highly stigmatized.  The social discomfort that PWID describe on entering pharmacies and SEPs may fall 
under the category of perceived injection drug use stigma. 
 Little quantitative research has been conducted on the effects of injection drug use stigma; 
however, one report has documented a positive association between drug use stigma and syringe 
sharing.  Among a sample of PWID recruited in Chennai, India, Latkin et al. found that perceived drug use 
stigma was positively associated with syringe sharing.89  The mechanism through which drug use stigma 
may influence syringe sharing was not investigated in this study, but more recent findings suggest that 
social discomfort may mediate these associations by acting as a barrier to sterile syringe access.  Among 
a sample of PWID in New York City, Rivera et al. found that higher levels of injection drug use stigma 
were associated with not accessing sterile syringes from SEPs or pharmacies in the past three months.90  
Additional research indicates that stigma is a powerful barrier to accessing health services in the context 
of several other health conditions as well, including HIV,91,92 depression,93 and obesity.94   
 Taken together, this evidence suggests that the social discomfort experienced by PWID as a 
result of perceived stigma experienced in pharmacies and SEPs may shape high-risk injection behavior 
(Figure 1.2).  PWID who feel uncomfortable acquiring syringes from pharmacies and SEPs may visit 
these venues less frequently and be more likely to obtain syringes from unsafe sources.  In addition, they 
may be less likely to have sterile syringes during injection episodes, and therefore, engage in higher rates 
of syringe sharing and syringe reuse.  To date, there have been no epidemiologic studies, of which I am 
aware, that have examined the influence of social discomfort on high-risk injection behaviors.  The 
qualitative and quantitative findings discussed above suggest that this may be a critical research gap. 
 
Social discomfort, neighborhood socioeconomic disadvantage, and high-risk injection behavior 
Recalling the risk environment paradigm once more, it is possible that relations between social 
discomfort and high-risk injection behavior are modified by other elements of the local area context.  
Neighborhood socioeconomic disadvantage, for example, may determine the extent to which high-risk 
injection behavior is shaped by social discomfort (Figure 1.2); however, the influence that this potential 
modifier may exert on relations between social discomfort and high-risk injection behavior is unclear.   
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Disadvantaged neighborhoods are typically characterized by a number of negative characteristics 
that increase the likelihood of risky injection behavior – a greater availability of syringes from unsafe 
sources, larger networks of PWID, and increased drug-related police activity.  Together, these attributes 
may enhance the negative influence of social discomfort.  PWID in poor areas may be more easily 
deterred from pharmacies and SEPs by feelings of discomfort than those in less disadvantaged areas 
due to the higher availability of injection equipment through alternative means – not only from unsafe 
syringe sources, but also from other injectors.  Fear of being stopped and hassled by police while carrying 
syringes may also serve to discourage PWID from overcoming social discomfort to utilize safe syringe 
sources.   
Alternatively, neighborhood disadvantage may buffer associations between social discomfort and 
high-risk injection behavior.  Although poor neighborhoods are generally deprived of resources, they have 
been targeted with HIV prevention services that may not be found in advantaged areas.  SEPs, for 
example, are likely more prevalent in poor neighborhoods.  As a result, relations between social 
discomfort and high-risk injection behavior may be may be weaker in these neighborhoods due to the 
higher availability of safe syringe sources for PWID.  In addition, SEPs promote harm reduction not only 
through the distribution of sterile injection equipment, but also by educating participants on the risks 
associated with unsafe injection.  This “risk awareness” may circulate through injection networks whose 
members reside close to SEPs, potentially making these PWID less likely to abandon safe syringe 
sources due to feelings of social discomfort. 
A second pathway through which neighborhood disadvantage may buffer the influence of social 
discomfort involves psychosocial factors.  PWID may possess a number of stigmatized characteristics 
that render them socially isolated from their communities.  Examples include their status as PWID, 
membership in ethnic/racial minority groups, low SES, homelessness, and a history of incarceration.   
Because these characteristics are more common in disadvantaged neighborhoods than in less 
disadvantaged ones, they may also be less stigmatized.  As a result, PWID in disadvantaged 
neighborhoods may have more social ties and social support than their counterparts in less 
disadvantaged areas.  Consequently, they may also be less easily deterred from utilizing safe syringe 
sources by feelings of social discomfort.  Evidence to support this hypothesis arises from studies linking 
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social support to increased health service utilization.  In a study conducted among HIV-positive, black 
PWID in Baltimore, Maryland, Knowlton and colleagues reported a positive association between social 
support and medical service use.95  Additional studies have found that social support is linked to 
participation in drug treatment and mental health service utilization among drug users.96,97 
 
Figure 1.2. Model of the influence of social discomfort surrounding the acquisition of sterile syringes on 




 Considering the evidence presented above, this dissertation will address three specific aims: 1) 
To systematically review the literature regarding the influence of neighborhood context on injection drug 
use behavior, 2) To determine whether neighborhood socioeconomic disadvantage is associated with 
high-risk injection behavior among PWID, and whether this association is modified by SEP accessibility 
and drug-related police activity, and 3) To determine whether social discomfort surrounding the 
acquisition of syringes from pharmacies and SEPs is associated with high-risk injection behavior, and 
whether this association is modified by neighborhood socioeconomic disadvantage.  
Social discomfort 
surrounding sterile 
syringe acquisi on 








CHAPTER 2: The influence of neighborhood context on injection drug use behavior: A systematic review 
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INTRODUCTION 
 Injection drug use continues to be an important public health problem worldwide.  Not only does 
this behavior increase the risk of soft-tissue infections such as abscesses and cellulitis, but it also 
facilitates the transmission of bloodborne viruses (BBVs), including human immunodeficiency virus (HIV), 
hepatitis C virus (HCV), and hepatitis B virus (HBV).2-5  In the United States, an estimated 8% of new HIV 
infections were attributable to injection drug use in 2010, while a further 3% occurred among individuals 
who engaged in both injection drug use and male-to-male sexual contact.6  Use of injection drugs was 
also reported by 62% of acute HCV patients and 23% of acute HBV patients who provided information on 
their drug use history in 2013.10 
In an effort to curb the use of injection drugs and associated practices that drive the transmission 
of BBVs, investigators have attempted to identify determinants of injection drug use behavior.  Much of 
this work has focused on factors operating at the individual level; however, studies have shown that 
interventions designed to change individual-level behavior among PWID are insufficient to eliminate their 
risk of BBVs.98,99  A review of HIV prevention interventions for PWID found that these interventions may 
only reduce the risk of unsafe injection practices by 25%.98  As a result, more recent research has begun 
to investigate the influence of forces beyond the level of the individual on injection drug use behavior.  
Numerous conceptual articles have discussed how factors operating in the social and structural 
environments may shape risk behavior among PWID.50,51,53  Rhodes and colleagues, for example, have 
posited that BBV transmission and injection risk behavior are determined, in large part, by the risk 
environment, or the space in which all factors exogenous to the individual interact to influence 
outcomes.53  According to this paradigm, BBV risk and injection practices among PWID are shaped by 
factors in the physical, social, political, and economic environments operating at micro, meso, and macro 
levels of influence. 
One element of the risk environment that has received increased attention in recent years is the 
neighborhood context.  The emergence of methods well-suited to the study of area-level phenomena, 
such as multilevel modeling and geographic information systems, has stimulated interest in the 
investigation of neighborhood health effects.  Neighborhood characteristics, such as socioeconomic 
disadvantage and social cohesion, have been identified as determinants of a variety of health conditions, 
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ranging from low birth weight to hypertension.55,100  More recently, studies have begun to examine 
elements of the neighborhood and spatial context as potential determinants of injection drug use 
behavior.  Existing research suggests that these local area characteristics may influence injection drug 
use behavior through several mechanisms, including sterile syringe availability and psychological 
distress.41,47   
Here, we undertake a systematic review of the literature regarding the influence of neighborhood 
context on injection drug use and associated behaviors.  We catalogue neighborhood and spatial 
characteristics that have been studied as potential correlates of injection drug use behavior and 
summarize these studies’ findings to identify elements of the local area context likely to shape BBV risk 





 We conducted a qualitative systematic review of the literature regarding the influence of 
neighborhood context on injection drug use behavior.  Quantitative meta-analyses were not possible due 
to the small number of studies identified pertaining to each neighborhood characteristic. 
 
Search strategy   
Our literature search was conducted using the PubMed, PsycInfo, and Web of Science 
databases.  Searches were limited to English-language journal articles published from 1995 to the date 
on which all searches were performed – December 12, 2014.  Each database was queried with two 
combinations of keywords:  (i) one pertaining to neighborhood context (e.g. ‘Community’, ‘Neighborhood’, 
‘Neighbourhood’, ‘Spatial’, ‘Area’, ‘Environment*’, ‘Place’, ‘Geographic’, ‘Context’), (ii) and a second 
pertaining to injection drug use behavior (e.g. ‘Intravenous drug’, ‘Injecting drug’, ‘Injection drug’, ‘Inject 
drugs’, ‘Injectors’).  The results of these searches were combined with the AND operator to generate a list 
of candidate articles related to the review topic.  For databases with controlled vocabularies (PubMed, 
PsycInfo), a second search was conducted using only controlled vocabulary terms.  Reference lists of 
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selected articles were hand-searched for additional studies.  A detailed description of the search strategy 
is provided in Appendix B. 
 
Study selection 
 Studies were chosen for inclusion in the review on the basis of three criteria.  First, selected 
studies must have investigated at least one individual-level outcome related to injection drug use 
behavior.  For the purposes of this review, the term injection drug use behavior refers to any behavior 
surrounding the use of injection drugs, such as injection frequency, injection cessation, syringe sharing, 
and the use of unsafe syringe sources.  Second, studies must have either assessed associations 
between neighborhood characteristics and injection drug use behavior, or investigated neighborhood 
characteristics as modifiers of the influence of other factors on injection drug use behavior.  Here, we 
define neighborhood characteristics as those measuring features of the physical, social, political, and 
economic environments on an infra-city scale.  These characteristics are often measured using one of 
four basic approaches: (i) a collective geographic approach, in which geographic space is divided into 
units and characteristics of the individuals within each unit are aggregated to create neighborhood-level 
measures, (ii) a spatial approach, in which the distance between a participant’s location (often the 
location of residence) and a second location are calculated to measure the geographic proximity of sites 
of interest, (iii) an observational approach, in which groups of researchers either directly observe or view 
video footage of neighborhoods to rate their characteristics, and (iv) a self-report approach, in which 
participants are asked to respond to items pertaining to attributes of their neighborhoods or their 
residential proximity to locations of interest.101  Studies were included regardless of the method used to 
measure neighborhood characteristics.  Third, analyses must have adjusted for potential confounders.   
Exclusion criteria were chosen to restrict the scope of the review to studies reporting 
generalizable results related to the influence of the local-area environment on individual-level outcomes 
among PWID.  Studies were excluded if they compared injection drug use behavior among PWID from 
only two neighborhoods, or if they assessed geographic variation in behavior without incorporating 





Systematic literature search 
 Our search yielded 4,578 articles, of which 65 were chosen for full-text examination after 
screening by title and abstract.  Of these 65 articles, 23 met our inclusion criteria.  One study was 
removed due to the use of poorly defined outcomes in the analysis, leaving 22 studies for inclusion in the 
review.  A hand search of the reference lists of these articles yielded no additional studies related to the 
review topic.  Figure 2.1 depicts the iterative process through which studies were identified. 
 
Description of included studies 
 All of the studies selected for review used data from the United States or Canada, with the 
exception of one study conducted in Glasgow, Scotland.  Eight studies used data from Baltimore, 
Maryland; five used data from New York, New York; three used data from San Francisco, California; and 
two used data from Montreal, Canada.  Seventeen studies utilized a cross-sectional study design, while 
the remaining five were longitudinal.  Nearly all of the studies concentrated on the influence of the 
residential neighborhood on injection drug use behavior, although two studies used the location of 
recruitment as the focus of the analysis.  Analyses were conducted using a diverse array of methods, 
including logistic regression, binomial regression, generalized estimating equations, multilevel modeling, 
and structural equation modeling.  Approximately half of the studies utilized an analytic approach that 
accounted for the clustering of participants within neighborhoods.  With the exception of four studies, all 
analyses were also adjusted for at least one individual-level socioeconomic indicator – either income, 
educational attainment, employment status, or receipt of government assistance. 
Several injection drug use behaviors were examined.  These included behaviors pertaining 
directly to the use of injection drugs, such as injection frequency and injection cessation, and behaviors 
associated with BBV transmission, such as injection equipment sharing.  Additional studies investigated 
behaviors surrounding the acquisition of sterile syringes from safe syringe sources.  All outcomes were 
ascertained via self-report.  Characteristics of the neighborhood context assessed in the studies could be 
grouped into two broad categories, which are discussed in the sections below: neighborhood 
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socioeconomic disadvantage and sterile syringe access.  Most studies utilized either a collective 
geographic approach or a spatial approach to measure features of the neighborhood context, although a 
small number of studies relied on participants’ self-reports.  When a collective geographic approach was 
used, administratively defined units of geography were most commonly utilized as neighborhood proxies.  
These ranged in size from census tracts to neighborhood statistical areas and health districts.  However, 
three studies approximated participants’ local area by creating buffers centered on the location of 
residence.  The results of all studies are described in Table 2.1.  Study findings are organized by 
neighborhood characteristic and injection drug use behavior in Table 2.2. 
 
Neighborhood socioeconomic disadvantage 
Neighborhood socioeconomic disadvantage and injection drug use among PWID 
Disadvantaged neighborhoods possess a number of characteristics that are hypothesized to 
increase injection drug use.  Abandoned buildings and substandard housing, for example, may serve as 
locations in which injection drugs are sold and consumed.  Unemployment may create populations of 
individuals with little time structure and low self-esteem, potentially increasing their risk of drug use and 
drug injection.  Simultaneously, violent crime may increase levels of psychological distress, predisposing 
community members to the use of injection drugs.102 
Although three studies were conducted on the relation between neighborhood socioeconomic 
disadvantage and injection drug use, all of these studies were conducted in Baltimore, Maryland using 
participants from the AIDS Linked to the Intravenous Experience (ALIVE) cohort.103-105  In each analysis, 
measures of neighborhood disadvantage were linked to increased injection drug use.  Nandi and 
colleagues analyzed the relation between neighborhood poverty and injection drug use among a sample 
of 1875 PWID from the ALIVE cohort.103  When traditional regression techniques were applied, no 
association was detected.  However, when confounding was controlled using inverse probability weights, 
the proportion of census tract residents living in poverty was positively associated with having injected 
drugs in the past six months.  In a similar analysis, Genberg and colleagues examined the relation 
between neighborhood deprivation and long-term injection cessation.104  In this study, neighborhood 
deprivation was measured using an index of eight census tract-level indicators, and long-term injection 
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cessation was defined as abstinence from injection drug use for three years.  Among a sample of 1697 
PWID from the ALIVE cohort, these authors found that living in the most deprived neighborhoods was 
inversely associated with long-term injection cessation.  In addition, relocation from the most deprived to 
a less deprived neighborhood was positively associated with injection cessation.  Linton and colleagues 
reported similar results in their examination of the relation between neighborhood residential rehabilitation 
and injection drug use, using a sample of 1818 PWID from the ALIVE cohort.  In this analysis, 
neighborhood residential rehabilitation was defined as the proportion of residential properties in 
participants’ neighborhood statistical area in which investment in interior or exterior maintenance 
exceeded $5,000 USD in a given year.  In comparison to neighborhoods with the lowest levels of 
rehabilitation, residence in neighborhoods with moderate and high levels of rehabilitation was associated 
with decreased injection drug use in the past six months.  Relocation from neighborhoods with low 
rehabilitation to moderate or high rehabilitation was also inversely associated with injection drug use. 
Two additional studies on neighborhood social disorder provide further support for the association 
between neighborhood disadvantage and injection drug use.  These analyses were conducted in 
Baltimore, Maryland using data from the SHIELD study and relied on participants’ self-reports to 
characterize their neighborhoods.41,106  Among a sample of 200 heroin injectors, Sherman and colleagues 
found that perceived severity of drug selling in the neighborhood was not associated with injection drug 
use in the past six months.106  However, participants who reported traveling within their neighborhoods of 
residence to buy drugs were more likely to report injection drug use in the past six months than those who 
did not.  Latkin and colleagues used similar methods to study the influence of neighborhood social 
disorder on injection frequency among a sample of 701 PWID.41  In this study, participants were asked to 
indicate “how big of a problem” each of the following was in their neighborhoods: vandalism, vacant 
housing, litter or trash on the street, loitering teens, burglary, drug selling, and robbery or assault.  They 
were also asked to complete a depression scale and to indicate how often they had used heroin, cocaine, 
and speedball in the past six months.  These items were subsequently used in structural equation models 
as manifest variables measuring neighborhood social disorder, psychological distress, and injection 
frequency, respectively.  Analyses indicated that neighborhood social disorder led to greater injection 
frequency by increasing injectors’ psychological distress. 
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 The consistency of results linking neighborhood socioeconomic disadvantage and neighborhood 
social disorder to injection drug use may be explained, in large part, by the fact that all of these studies 
were conducted in the same city using similar study populations.  However, these results are made more 
robust by the fact that significant associations were detected in all analyses despite the wide variety of 
measures used.  Neighborhood socioeconomic disadvantage was operationalized as census tract-level 
poverty, an index of eight census tract-level indicators, and as residential rehabilitation, which was 
measured at the level of the neighborhood statistical area.  Neighborhood social disorder was measured 
through participants’ self-reports, but still yielded results consistent with those generated using 
administrative data.  Furthermore, the studies on neighborhood socioeconomic disadvantage were 
prospective, providing additional evidence of a causal relation between disadvantage and injection drug 
use.  The detection of an inverse association between moving to a wealthier neighborhood and the use of 
injection drugs is especially compelling.  Together, this evidence suggests that neighborhood 
disadvantage may increase injection drug use, although additional studies are urgently needed in other 
geographic contexts. 
 
Neighborhood socioeconomic disadvantage and injection risk behavior 
 Neighborhood socioeconomic disadvantage has been hypothesized to increase, not only injection 
drug use, but also injection risk behaviors that facilitate the transmission of BBVs.  Many of the same 
social and structural pathways that have been theorized to fuel injection drug use may mediate relations 
with injection risk behavior as well.  For example, the prevalence of abandoned buildings may foster the 
development of drug markets from which PWID can obtain contaminated injection equipment.  In addition, 
violent crime may increase psychological distress, making PWID more likely to engage in risky injection 
practices, such as syringe sharing.41 
Two studies examined associations between measures of neighborhood socioeconomic 
disadvantage and injection risk behavior.41-43  The results of these analyses were mixed.  Among a 
sample of 4,589 PWID in the San Francisco Bay area, Bluthenthal and colleagues found that percent of 
households on public assistance, percent male unemployment, median household income, and an index 
of neighborhood deprivation (all of which were measured at the census tract level) were not associated 
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with either receptive syringe sharing or distributive syringe sharing in the past six months.42  However, the 
proportion of African American residents in the census tract was associated with a decreased likelihood of 
both receptive syringe sharing and distributive syringe sharing.  A similar study conducted by Genereux 
and colleagues in Montreal, Canada evaluated the influence of neighborhood socioeconomic 
disadvantage and low neighborhood educational attainment on high-risk injection behavior among a 
sample of 219 inner-city PWID.43  Analyses revealed that neighborhood disadvantage was positively 
associated with high-risk injection behavior, while low neighborhood educational attainment was inversely 
associated with this outcome.  Neither neighborhood disadvantage nor neighborhood educational 
attainment were associated with high-risk injection behavior among 249 PWID in boroughs outside the 
inner-city area.   
In addition to the two studies investigating associations between measures of neighborhood 
socioeconomic disadvantage and injection risk behavior, the study by Latkin and colleagues described in 
the last section included analyses on the relation between perceived neighborhood social disorder and 
injection equipment sharing.41  Structural equation models suggested that psychological distress was 
greater in more disordered neighborhoods and that distress led to more frequent injection equipment 
sharing. 
The dearth of studies and inconsistency of results pertaining to links between neighborhood 
disadvantage and injection risk behavior prevent us from drawing conclusions with respect to the 
existence of this relation.  The contradictory nature of the findings may be explained, in part, by the 
limitations of each analysis.  For example, Bluthenthal and colleagues acknowledged some ambiguity in 
assigning participants to census tracts, which may have biased the results of their analysis toward the 
null.  Conversely, the study by Genereux and colleagues was limited by small sample sizes.  Whereas the 
Bluthenthal study included over 4,500 participants, the Genereux study included only 219.  As a result, 
coefficient estimates from regression models used to measure associations may have been unstable.  
This would help explain why the association between neighborhood socioeconomic disadvantage and 
high-risk injection behavior was in the opposite direction of that between low neighborhood educational 
attainment and the same outcome, despite the fact that these measures of disadvantage were positively 
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correlated.  Overall, additional studies on the influence of neighborhood socioeconomic disadvantage on 
injection risk behavior are needed to make a determination as to how these constructs may be related. 
 
Sterile syringe access 
Spatial access to syringe exchange programs and syringe exchange program utilization 
In many cities across the United States and abroad, syringe exchange programs (SEPs) have 
been implemented to curb the transmission of BBVs among PWID.  These programs operate fixed sites 
and mobile outreach teams from which PWID can access sterile injecting equipment, including syringes, 
cookers, filters, and water.  Extensive research has shown that participation in SEPs decreases both 
syringe sharing and the incidence of BBVs.9,25-28,107  As a result, investigators have hypothesized that 
increased spatial access to these programs increases their utilization and decreases injection risk 
behavior. 
Three studies evaluated the relation between spatial SEP access and SEP utilization, all of which 
found that living closer to an SEP site was associated with increased SEP use.44,108,109  Among a sample 
of 776 PWID in New York City, Rockwell and colleagues found that participants who reported living within 
a 10-minute walk of a SEP were more likely to obtain needles from SEPs than those who lived farther 
away.44  Similarly, in a longitudinal study of all participants in the Baltimore Needle Exchange Program 
(BNEP) (N=12,388), Gindi and colleagues found that PWID whose zip codes matched those of the BNEP 
site at which they enrolled were more likely to visit a BNEP site at least once within the next 12 months in 
comparison to those who reported a different zip code.108  Finally, among a sample of PWID in 
Philadelphia, Pennsylvania, Williams and Metzger found that the distance from participants’ residences to 
the nearest SEP site was positively associated with reporting a non-SEP as the usual syringe source.109  
Additional analyses from this study suggest that spatial access to SEPs from non-residential locations 
may influence SEP utilization as well.  These analyses found that Latinos were more likely than whites to 
report non-SEPs as their usual syringe source as the distance from the nearest SEP to drug buy and 
injection locations increased. 
Although the number of studies conducted on the association between spatial access to SEPs 
and SEP utilization is small, their results are remarkably consistent.  These findings are especially 
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compelling in light of the fact that these studies were conducted in three different cities using both 
objective and self-reported measures of SEP proximity.  Additional studies are needed to corroborate 
these results; however, current evidence supports a positive relation between spatial access to SEPs and 
SEP utilization. 
 
Spatial access to syringe exchange programs and injection risk behavior 
Six studies examined the relationship between spatial access to SEPs and injection risk 
behavior.44-47,60,110  Of these six studies, only three identified significant associations in the hypothesized 
direction.  Among a sample of 776 PWID in New York City, Rockwell and colleagues found that 
participants who reported living within a 10-minute walk of an SEP site were less likely to have engaged 
in receptive syringe sharing at the last injection in comparison to participants who lived farther away.44  
Similarly, among a sample of 2,567 PWID in Glasgow, Scotland, Hutchinson and colleagues found that 
participants who resided more than one mile from an SEP site were more likely to have injected with a 
used needle or syringe in the past six months than those who lived in closer proximity.45  Additional 
evidence was reported by Cooper and colleagues in a serial cross-sectional analysis of 4,003 PWID 
entering a detoxification program in New York City between 1995 and 2006.47  In this analysis, increases 
in spatial SEP access over time were associated with increased sterile syringe use.  Of note, Cooper and 
colleagues also used this study sample to investigate whether relations between spatial SEP access and 
injection risk behavior were modified by drug-related police activity.  These analyses suggested that the 
protective effect of spatial SEP access against unsterile syringe use was attenuated by drug-related 
police activity.48,49 
 The remaining three studies on spatial SEP access and injection risk behavior found that these 
constructs were not associated.  Among a sample of 587 PWID in New York City, Schilling and 
colleagues found that participants recruited within 10 blocks of an East Harlem SEP site were no less 
likely than participants recruited farther away to share needles with others, use dirty needles by 
themselves, or share the same cooker.46  Bruneau and colleagues also found no association between 
spatial SEP access and high-risk injection behavior.  In this Montreal-based study, SEP access was 
defined as the distance from participants’ postal code of residence to the nearest SEP site.60  Finally, 
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among a sample of 989 PWID in San Francisco, California, Martinez and colleagues found no association 
between SEP accessibility and receptive or distributive syringe sharing in the past six months.110 
 Together, the results of these studies provide reasonably consistent support for an inverse 
association between spatial SEP access and injection risk behavior.  Although half of the studies on this 
relation reported null results, their findings may be explained by the measures used to operationalize the 
constructs of interest.  For example, the study by Schilling and colleagues relied on the location of 
recruitment to separate participants into those with high and low spatial SEP access.  However, the 
location of recruitment may not have accurately reflected the geographic space in which participants 
spent most of their time, and therefore, may have led to their misclassification.  Such misclassification 
may have biased the results of this analysis toward the null.  A similar problem may have produced the 
null findings reported by Martinez and colleagues.  In this study, SEP accessibility was defined as 
whether an SEP site was located within 50 meters of a participant’s activity space route (the path 
connecting the locations where a participant usually slept, hung out, and used drugs in the past 6 
months).  This measure may have misclassified participants’ level of SEP access because SEP sites may 
have been located in close proximity to spaces frequented by PWID, but not located on their activity 
space routes.  Again, associations may have been biased toward the null.  Finally, the null result reported 
by Bruneau and colleagues may be explained by the injection risk behavior modeled in their analysis.  
The studies that detected associations in the hypothesized direction used measures of syringe sharing 
and unsterile syringe use as outcomes.  However, Bruneau and colleagues used high-risk injection 
behavior, which they defined as agreement with any of the following in the past six months: having 
borrowed a syringe or shared injection material at least five times, having injected with groups of 
strangers at least five times, or having borrowed a syringe or shared injection material with a known HIV-
positive person.  It is possible that spatial SEP access may be inversely associated with sharing injection 
material, but not with injecting among strangers or with sharing injection material with a known HIV-
positive person.  The inclusion of these elements in the definition of high-risk injection behavior may have 
caused associations with spatial SEP access to be null. 
 
Spatial access to pharmacies selling syringes over-the-counter and pharmacy syringe purchases  
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Numerous states have expanded sterile syringe access to PWID, not only through SEPs, but also 
through the legalization of non-prescription syringe sales from pharmacies.  Pharmacies are open for 
longer hours than SEPs and may be more conveniently located for PWID to access.  As a result, they 
serve as an important alternative syringe source for PWID and may reach populations of injectors who do 
not use SEPs.34  Similar to hypotheses regarding the influence of spatial SEP access, spatial access to 
pharmacies selling syringes over-the-counter has been theorized to increase pharmacy syringe 
purchases and decrease injection risk behavior. 
Only one study examined relations between measures of spatial pharmacy access and pharmacy 
syringe purchases.111  Among a sample of 563 PWID in San Francisco, California, Stopka and colleagues 
tested four measures of pharmacy proximity as potential determinants of pharmacy syringe purchase in 
the past six months: Euclidian distance from the participant’s usual residence to the nearest pharmacy 
selling syringes over-the-counter, walking distance to the nearest pharmacy, walking time to the nearest 
pharmacy, and number of pharmacies within a 0.25-mile radius of the participant’s usual residence.111  No 
associations were found between these measures and the likelihood of pharmacy syringe purchase.  
Associations between spatial pharmacy access and injection risk behavior were investigated in 
four analyses.47-49,60  The first, conducted by Bruneau and colleagues among PWID in Montreal, Canada, 
found no association between Euclidean distance from participants’ postal code of residence to the 
nearest pharmacy and high-risk injection behavior.60  The subsequent three analyses were conducted by 
Cooper and colleagues using the same sample of New York City-recruited PWID described in the section 
above.47-49  In all three analyses, increased spatial access to pharmacies selling syringes over-the-
counter was associated with decreased unsterile syringe use. 
Given the dearth of evidence on the effects of spatial pharmacy access, the influence of this 
construct on pharmacy syringe purchases and injection risk behavior is unclear.  As above, the 
inconsistency of results regarding injection risk behavior may be attributable to the use of different 
outcome measures.  However, additional research is needed to better understand how spatial pharmacy 




 Additional studies have begun to examine other aspects of the neighborhood context as potential 
determinants of injection drug use behavior.  Although current evidence is insufficient to evaluate their 
influence on PWID, this evidence is described below.  
 
Spatial access to other health services and health service utilization 
Closely akin to analyses examining the influence of proximity on the use of SEPs and 
pharmacies, two studies examined whether spatial access to other health services was associated with 
their use.112,113  Among a sample of 219 Mexican American heroin injectors in Houston, Texas, Kao and 
colleagues investigated whether the proximity and density of substance abuse treatment facilities was 
associated with seeking or receiving substance abuse treatment.112  These associations were null, even 
after substance abuse treatment facilities were restricted to those offering services in Spanish.  In a 
similar study, Hadland and colleagues investigated the relation between spatial access to a supervised 
injection facility (SIF) and recent facility use.  Among a sample of 414 adolescent and young adult PWID 
in Vancouver, Canada, they found that participants who lived or spent time in the neighborhood 
surrounding the SIF were more likely to report having used the facility. 
 
Neighborhood context as an effect modifier 
Finally, one study examined neighborhood-level characteristics as potential effect modifiers of an 
association observed at the individual level.114  Among a sample of 144 PWID in Baltimore, Maryland, 
Fuller and colleagues conducted an analysis to determine whether census tract-level socioeconomic and 
demographic characteristics modified the relation between race and age at initiation of injection drug 
use.114  Analyses revealed that the relation was not modified by the proportion of census tract residents 
living in poverty or the proportion of employed men ≥16 years of age.  However, a significant three-way 
interaction was detected between race, the proportion of residents with at least a high school education, 
and the proportion of minority residents.  African American PWID who lived in neighborhoods with high 
percentages of minority residents and fewer high school graduates were more likely to report initiation of 
drug injection before age 22 in comparison to white PWID living in neighborhoods with low minority 





Our systematic review summarizes the extant literature about the influence of neighborhood 
context on injection drug use behavior.  This is an emerging area of research, and as a result, we found 
that few published analyses exist on this topic.  Although our ability to make definitive conclusions with 
regard to specific temporal and causal relationships was limited, existing research suggests that certain 
aspects of the neighborhood environment may shape behavior among PWID.  Early evidence suggests 
that neighborhood socioeconomic disadvantage may be related to increased injection drug use, although 
further studies of this association are needed in different geographic contexts.  The relation between 
neighborhood socioeconomic disadvantage and injection risk behavior is less clear, given the 
inconsistency of extant results.  However, reasonably consistent support links spatial SEP access to 
increased SEP utilization and decreased injection risk behavior.  The existence of a relation between 
spatial pharmacy access and injection drug use behavior remains unclear. 
 
Limitations of the extant literature 
The literature on neighborhood and injection drug use behavior is limited not only by a dearth of 
studies, but also by a number of methodological and conceptual challenges.  We discuss these limitations 
below and offer recommendations for future research. 
 
Few longitudinal studies 
Our current understanding of links between neighborhood context and injection drug use behavior 
is limited by the small number of longitudinal studies that have been conducted on this topic.  Cross-
sectional studies are often more practical to conduct, given the financial and temporal burdens associated 
with the collection of longitudinal data, and as a result, the majority of studies included in this review were 
cross-sectional in nature.  However, longitudinal studies are necessary to establish temporality and to 
appropriately measure neighborhood effects.  Associations detected between neighborhood 
characteristics and injection drug use behavior among PWID in cross-sectional studies may be the 
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spurious byproduct of selection into neighborhoods on the basis of individuals’ injection drug use.  For 
example, individuals who initiate drug injection may experience a decline in their individual socioeconomic 
status, leading them to relocate to poorer neighborhoods with greater social disorder.  A cross-sectional 
study of the relation between neighborhood social disorder and injection drug use might then detect an 
association between these constructs, although a causal relation may not exist.  Longitudinal studies that 
relate neighborhood characteristics to changes in injection drug use behavior over time are necessary to 
avoid this threat to causal inference.  Future research should also track the mobility of PWID over time to 
study the cumulative effect of neighborhood exposures on outcomes associated with injection drug use.   
 
Inconsistent measurement of neighborhood characteristics 
The literature reviewed above is also limited by the lack of consistency with which neighborhoods 
were defined and measured.  Although census tracts were often used as proxies for neighborhood, larger 
geographic units, including neighborhood statistical areas and health districts, were also used to measure 
area-level effects.  The lack of agreement regarding the spatial scale on which neighborhoods should be 
defined makes it difficult to compare results across studies, and subsequently, to draw conclusions with 
respect to the influence of neighborhood on injection drug use behavior.  Additional studies are needed to 
explore the measurement of area-level characteristics in the context of outcomes associated with 
injection drug use.  However, it is important to note that the method through which neighborhoods are 
defined and measured will likely vary with the constructs under study.  For example, when examining the 
influence of a social construct, like collective efficacy, it may be appropriate to rely on participants’ 
perceptions of their neighborhoods, whereas structural constructs, like SEP availability, may be better 
studied using geographically-defined areas.  Although administratively-defined units are often used to 
approximate neighborhoods, as was the case for several analyses in this review, these units may not 
necessarily reflect the geographic space to which individuals are exposed.  Therefore, future studies 
should use ego-centered areas (e.g. buffers centered on participants’ residences) or GPS activity spaces 
to approximate neighborhoods of interest whenever possible.115  The radii of ego-centered areas could 




Studies conducted in few research settings 
Another limitation of the extant literature on neighborhood context and injection drug use behavior 
is the limited generalizability of the settings in which the studies were conducted.  As described above, all 
of the studies identified for inclusion in this review utilized data from the United States, Canada, or 
Scotland.  These are all developed country contexts, in which the relation between neighborhood and 
injection drug use behavior may not reflect that in parts of the world where resources are more scarce 
and the stigma associated with injection drug use may vary.  Data have shown that developing regions, 
such as Eastern Europe and South America, have some of the highest prevalences of injection drug use 
and BBVs among PWID.11,116  Additional research on how neighborhood and other elements of the risk 
environment influence injection drug use behavior in these regions is urgently needed to curb epidemics 
of injection drug use and BBVs worldwide. 
A related issue is the fact that nearly all of the reviewed studies examined data from urban 
environments.  Although the density of the drug injecting population may be higher in cities than in 
suburban or rural areas, injection drug use behaviors occurring outside of urban contexts should not be 
ignored.  This point is particularly salient considering the impact that prescription opioid abuse has had on 
the geographic distribution of heroin use in the United States.  Prescription opioid abuse has become 
especially prevalent in suburban contexts, where residents are more likely to have health insurance, and 
therefore, access to prescription drugs.  As prescription opioids have become more expensive and less 
readily available for non-medical use, some opioid abusers have shifted to heroin, progressing in some 
cases to heroin injection.117-128  As a result, although heroin use has traditionally been concentrated in 
inner-city, minority neighborhoods, recent research has shown that new heroin users are more likely to 
reside outside of large urban areas in neighborhoods with predominantly white populations.129  Critically, 
both healthcare and harm reduction resources targeted to PWID may be less available in these settings, 
making injectors in these areas especially vulnerable to the harms associated with injection drug use.  
Under these conditions, BBVs may be more easily transmitted and go undetected for longer periods, 
fostering the development of BBV epidemics.  Future studies are needed to examine how neighborhood-
level factors shape injection drug use behavior in non-urban areas. 
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Furthermore, nearly all of the literature about neighborhood context and injection drug use 
behavior is focused on the influence of the residential neighborhood.  While the residential context is 
likely an influential element of the risk environment, other spatial locations may be of importance as well.  
Two contexts that warrant further study are the areas surrounding the drug-buy and injection locations.  
For many PWID, the residential, drug-buy, and injection locations may be in such close geographic 
proximity that it is not possible to disentangle the independent influence of each on injection drug use 
behavior.  However, current evidence indicates that at least some PWID commute among these 
locations, creating the opportunity to examine the potential influence of each local-area context 
separately.109,110  When designing harm reduction interventions geared toward PWID, it may ultimately 
prove more effective to target areas in which drugs are purchased and used as opposed to 
neighborhoods in which PWID live. 
  
Few neighborhood characteristics have been investigated 
Our ability to draw conclusions regarding the influence of neighborhood context on injection drug 
use behavior was also curtailed by the fact that few neighborhood-level characteristics have been 
examined as potential determinants of behavior among PWID.  As described above, the only features of 
the local environment that have been studied in any depth are neighborhood socioeconomic context, SEP 
proximity, and pharmacy proximity.  Beyond deepening our knowledge of neighborhood characteristics 
that have already been investigated, future research should also incorporate elements of the 
neighborhood context that have yet to be studied.   
Many aspects of the social environment, in particular, deserve further inquiry.  Examples include 
collective efficacy, social capital, and the stigma associated with injection drug use.  Collective efficacy, 
defined as a combination of social cohesion and the willingness to take civic action,130 has been shown to 
impact violence,131 asthma,132 birth weight,133 and age at first sexual intercourse.134  Given the diversity of 
outcomes to which this construct has already been linked, collective efficacy may influence injection drug 
use behavior as well.  Similarly, social capital has been described as an indicator of access to resources 
and can be measured at both the individual and neighborhood levels.135  Studies have shown that social 
capital is linked to substance use and potentially HIV status,136-142 suggesting that it may shape behaviors 
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surrounding drug injection as well.  Less work has been conducted on the influence of injection drug use 
stigma, but this is another potentially fruitful area of inquiry.  Existing evidence suggests that health-
related stigma may pose a barrier to accessing health and social services.91,143-145  PWID who reside in 
communities with the highest levels of injection drug use stigma may experience increased psychological 
distress and be less likely to access syringes from safe sources.  As a result, these PWID may be more 
likely to engage in high-risk injection behaviors. 
 
Inadequate examination of mediators and modifiers 
Developing our understanding of the influence of neighborhood on injection drug use behavior will 
also require the identification of factors that mediate and modify these relationships.  However, few of 
these third variables have been investigated.  Of the 22 studies reviewed above, only one included a 
potential mediator,41 while few others examined effect modification.  The identification of both mediators 
and modifiers will be necessary to intervene effectively on elements of the neighborhood context that 
shape injection drug use behavior.  Mediators may represent additional targets for intervention, while 
modifiers may identify populations in which these interventions will have the greatest effect.  For example, 
neighborhood-behavior relations may be modified by individual-level sociodemographic characteristics 
(e.g. gender, age, race).  Targeting interventions to groups that are most affected by characteristics of the 
neighborhood environment may increase their public health impact. 
Finally, investigating the interplay of neighborhood-level factors in shaping injection drug use 
behavior should not be under-emphasized.  The studies included in this review identified multiple 
elements of the neighborhood context that may influence outcomes among PWID; however, only two 
analyses sought to understand how the effect of one area-level characteristic was modified by the 
presence of another.48,49  These are the analyses by Cooper and colleagues in which drug-related police 
activity was investigated as a potential modifier of associations between spatial SEP access and unsterile 
syringe use.  A complete understanding of how local environments shape injection drug use behavior will 
require further examination of both mediating and modifying pathways. 
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Strengths and limitations of the review 
The findings in this review should be considered in light of specific strengths and limitations.  With 
regard to strengths, this is the first systematic review, of which we are aware, to summarize and 
synthesize the literature about the relation between neighborhood context and injection drug use 
behavior.  Describing the work that has been done in this field may motivate future research on the 
influence of neighborhood-level factors on PWID.  Second, a very large number of abstracts was 
screened (n = 4,578) to ensure that all extant studies pertaining to our topic were identified.  The fact that 
no additional studies were identified by a hand search of selected articles’ citations supports the notion 
that our original search strategy was comprehensive. 
With regard to limitations, our search was restricted to articles published in the peer-reviewed 
literature.  Therefore, articles from the grey literature were not included, and it is possible that our findings 
were influenced by publication biases toward positive results.  Second, the relatively small number of 
studies included in the review prevented us from using meta-analyses to investigate relations between 
elements of the neighborhood context and injection drug use behavior. 
 
Conclusion 
 Quantitative analyses regarding the influence of neighborhood-level characteristics on PWID are 
only beginning to emerge.  Our systematic review of this literature has identified both methodological 
challenges and gaps in current knowledge that highlight the need for additional research on this topic.  As 
studies on injection drug use behavior move beyond the identification of individual-level determinants, 
enhancing our understanding of pathways linking neighborhood-level factors to individual behavior among 
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Figure 2.1. Process through which articles were identified for inclusion in the review (See Appendix B for 










Location Sample Contextual variables 


























of the census tract of 
residence: 
• Percent of households on 
public assistance 
• Percent male 
unemployment 
• Median household income 
• Percent African American 
• Global measure of 
neighborhood deprivation 
• Receptive syringe 
sharing in the past 6 
months 
• Distributive syringe 
sharing in the past 6 
months 
A 10% increase in the percent of 
residents in the census tract who 
identified as African American was 
associated with modest decreases in the 
likelihood of both receptive syringe 
sharing (AOR=0.93, 0.89-0.99) and 
distributive syringe sharing (AOR=0.94, 
0.89-0.99).  None of the other 
neighborhood-level characteristics 
examined were significantly associated 
with syringe sharing in adjusted models. 
Bruneau et 
al. 2008 60 
Cross-
sectional 


















Euclidean distance in 
meters from each 
participant’s postal code of 
residence to: 
• The nearest SEP site 
• The nearest pharmacy 
• High-risk injection 
behavior, defined as  
agreement with any of 
the following in the past 
6 months: 
1) Having shared 
injection material at least 
5 times 
2) Having injected with 
strangers at least 5 
times 
3) Having shared 
injection material with a 
known HIV-positive 
person 
Neither proximity to SEP sites nor 
proximity to pharmacies selling syringes 
over-the-counter were associated with 









Location Sample Contextual variables 




al. 2011 47 
Serial cross-
sectional 
analysis of the 
influence of 
spatial access 




















• Spatial access to SEP 
sites, defined as the percent 
of the health district of 
residence within 0.25 miles, 
0.5 miles, and 1 mile of an 
SEP site 
• Spatial access to 
pharmacies, defined as the 
percent of the health district 
of residence within 0.25 
miles, 0.5 miles, and 1 mile 
of a pharmacy selling 
syringes over-the-counter 
• Use of a sterile syringe 
in ≥75% of injection 
events in the past 6 
months 
When 1 mile-radii were used to measure 
SEP access, higher SEP access was 
associated with increased sterile syringe 
use.  Effect estimates generated by the 
use of 0.25 mile and 0.5 mile radii were 
similar in magnitude and direction.  
 
When spatial access to pharmacies 
selling syringes over-the-counter was 
added to these models, higher pharmacy 
access was also associated with 
increased sterile syringe use.  SEP 
access coefficients were unaffected by 
the addition of a pharmacy access 
variable to the model. 
Cooper et 
al. 2012a 48 
Serial cross-
sectional 
analysis of the 
influence of 
spatial access 
























• Spatial access to SEP 
sites, defined as the percent 
of the health district of 
residence within 1 mile of 
an SEP site 
• Drug-related arrest 
rate/1000 adults in the 
health district of residence 
• Spatial access to 
pharmacies, defined as the 
percent of the health district 
of residence within 1 mile of 
a pharmacy selling syringes 
over-the-counter 
• Use of an unsterile 
syringe in ≥75% of 
injection events in the 
past 6 months 
• Distributive syringe 
sharing in the past 6 
months 
In health districts with low drug-related 
arrest rates, higher SEP access in 1995 
was associated with decreased unsterile 
syringe use.  Higher drug-related arrest 
rates appeared to erode this protective 
effect; however, changes in SEP access 
and drug-related arrest rates after 1995 
were not associated with unsterile 
syringe use.  Increased pharmacy access 
was linked to decreased unsterile syringe 
use. 
 
A marginal inverse association was 
observed between SEP access and 
distributive syringe sharing, while drug-
related arrest rates and pharmacy access 
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al. 2012b 49 
Serial cross-
sectional 





























• Spatial access to sterile 
syringes from SEP sites, 
defined as the average 
number of syringes 
distributed by SEPs across 
the health district of 
residence 
• Drug-related arrest 
rate/1000 adults in the 
health district of residence 
• Spatial access to 
pharmacies, defined as the 
percent of the health district 
of residence within 1 mile of 
a pharmacy selling syringes 
over-the-counter 
• Use of an unsterile 
syringe in ≥75% of 
injection events in the 
past 6 months 
In health districts with low drug-related 
arrest rates, higher access to SEP 
syringes in 1995 was associated with 
decreased unsterile syringe use.  Higher 
drug-related arrest rates appeared to 
erode this protective effect.  Although no 
association was observed between 
changes in drug-related arrest rates after 
1995 and unsterile syringe use, a 
marginal inverse association was 
detected between changes in SEP 
syringe access after 1995 and this 
outcome.  Increased pharmacy access 
was also linked to decreased unsterile 
syringe use. 



















years who had 
been injecting 
for 2-5 years 
and were 











of the census tract in which 
participants were recruited: 
• Percent of residents living 
in poverty 
• Percent employed among 
adults ≥16 years of age 
• Percent of residents with a 
high school diploma or 
equivalent 
• Percent minority residents 
• Age at initiation of 
injection drug use 
The association between race and age at 
initiation of injection drug use was 
modified by neighborhood minority 
composition and educational attainment 
in a three-way interaction.  African 
Americans who lived in neighborhoods 
with high percentages of minority 
residents and low levels of educational 
attainment were nearly 4 times as likely 
to initiate injection drug use during 
adolescence as their white counterparts 
living in neighborhoods with low minority 
percentages and higher educational 
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al. 2011 104 
Longitudinal 


















• Neighborhood deprivation, 
defined as the score on an 
index created from 8 census 
tract-level characteristics of 
the census tract of 
residence 
• Long-term injection 
cessation, defined as 
abstinence from injection 
drug use for 6 
consecutive study visits 
(3 years) 
Increased neighborhood deprivation was 
associated with decreased long-term 
injection cessation.  Similarly, compared 
with continuously living in less deprived 
neighborhoods, staying in the most 
deprived neighborhoods was associated 
with decreased long-term injection 
cessation.  Relocating from the most 
deprived to less deprived neighborhoods 
was associated with increased long-term 
injection cessation, as was relocating 
within less deprived neighborhoods.  
There was no association between long-
term injection cessation and moving 
within the most deprived neighborhoods 
or moving from a less deprived 
neighborhood into the most deprived 
neighborhoods. 
Genereux 
















enrolled in the 
St. Luc Cohort 
• Neighborhood 
socioeconomic 
disadvantage, defined as 
the percent of households 
below the low-income cutoff 
(LICO) within a circular 
500m-radius buffer centered 
on participants’ residential 
postal code  
• Neighborhood educational 
attainment, defined as the 
percent of adults with a 
university degree in the 
same 500m-radius buffer 
• High-risk injection 
behavior, defined as  
agreement with any of 
the following in the past 
6 months: 
1) Having shared 
injection material at least 
5 times 
2) Having injected with 
strangers at least 5 
times 
3) Having shared 
injection material with a 
known HIV-positive 
person 
Among PWID in the inner city, 
neighborhood socioeconomic 
disadvantage was associated with 
increased high-risk injection behavior, 
while low neighborhood educational 
attainment was associated with 
decreased high-risk injection behavior. 
 
Neighborhood socioeconomic 
characteristics were not associated with 
high-risk injection behavior among PWID 








Location Sample Contextual variables 
Injection drug use 
behavior outcome 
Results 
Gindi et al. 
2009 108 
Longitudinal 















• Proximity to the BNEP site 
at which participants 
enrolled in the program, 
defined as whether the 
client's zip code at 
enrollment matched the zip 
code of the BNEP site 
where the client enrolled 
• Multi-visit usage of the 
BNEP, defined as 
visiting a BNEP site at 
least once in the 12 
months following the 
enrollment visit 
• Number of return visits 
to BNEP sites during the 
first 12 months of 
enrollment 
PWID whose zip code matched that of 
the BNEP site at which they enrolled 
were 49% more likely to visit a BNEP site 
at least once within the next 12 months in 
comparison to PWID who reported a 
different zip code (AOR=1.49, 1.38-1.62).  
In addition, PWID whose zip code 
matched that of the enrollment site 
visited BNEP locations at more than 4 
times the rate of their counterparts who 
reported different zip codes (Adjusted 
IRR=4.16, 2.64-6.56). 
Hadland et 
al. 2014 113 
Cross-
sectional 














enrolled in the 
At-Risk Youth 
Study cohort 
• Having lived or spent time 
in Downtown Eastside (the 
neighborhood surrounding 
Vancouver's SIF) in the past 
6 months 
• Use of Vancouver's SIF 
in the past 6 months 
Adolescent and young adult PWID who 
lived or spent time in the neighborhood 
surrounding Vancouver's SIF (Downtown 
Eastside) were more than three times as 
likely to report SIF use as those who did 
not (AOR=3.29, 2.38-4.54). 
Hutchinson 












2,567 PWID • Proximity to an SEP site, 
defined as the direct 
distance in miles from the 
center of each participant's 
postcode district of 
residence to the nearest 
SEP site 
• Injection with a used 
needle or syringe in the 
past 6 months 
PWID who resided >1 mile from an SEP 
site were marginally more likely to have 
injected with a used needle or syringe in 
the past 6 months in comparison to their 
counterparts who lived ≤1 mile from an 








Location Sample Contextual variables 
Injection drug use 
behavior outcome 
Results 




























Minutes of driving time from 
a participant’s residence to: 
• The closest substance 
abuse treatment facility 
• The closest substance 
abuse treatment facility 
providing services in 
Spanish 
 
Number of substance abuse 
facilities within a 10-minute 
driving distance of a 
participant’s residence, 
including: 
• All facilities 
• Facilities providing 
services in Spanish 
• Ever sought substance 
abuse treatment 
• Ever received 
substance abuse 
treatment 
• Location of last heroin 
purchase, defined as 




No associations were found between any 
of the variables measuring spatial 
accessibility of substance abuse 
treatment facilities and having sought or 
received treatment.  However, current 
heroin users who lived near a greater 
number of Spanish-serving treatment 
facilities were more likely than former 
heroin users who lived near fewer 
Spanish-serving facilities to purchase 
their last heroin inside their neighborhood 
of residence.  Similarly, current heroin 
users who resided farther from a 
Spanish-serving facility were less likely 
than former heroin users who resided 
closer to a Spanish-serving facility to 
purchase their last heroin inside their 
neighborhood of residence. 
Latkin et 
al. 1998 146 
Cross-
sectional 




high drug use 
areas on the 
type and 
frequency of 




enrolled in the 
Stop AIDS for 
Everyone 
(SAFE) study, 




Distance in meters from the 
participant’s residence to: 
• The SAFE study clinic  
• The Baltimore City Health 
Department's Western 
District STD Clinic 
 
NOTE: The SAFE study 
clinic and the Western 
District STD clinic were 
chosen to represent areas 
of Baltimore with a high 
prevalence of drug users. 
• Daily heroin injection in 
the past 6 months 
• Daily cocaine injection 
in the past 6 months 
After controlling for a variety of 
neighborhood socioeconomic and 
demographic characteristics, distance 
from the participant's residence to the 
Western District STD clinic was inversely 
associated with daily cocaine injection, 
and not associated with daily heroin 
injection.  Distance to the SAFE study 
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al. 2005 41 
Cross-
sectional 


















• Neighborhood social 
disorder, measured by 7 
items asking participants 
how big of a problem each 
of the following was in their 
neighborhoods: vandalism, 
vacant housing, litter or 
trash on the street, loitering 
teens, burglary, drug selling, 
and robbery or assault 
• Injection frequency in 
the past 6 months 
• Injection equipment 
sharing in the past 6 
months 
Structural equation models were used to 
measure the influence of neighborhood 
social disorder on injection frequency and 
equipment sharing, including 
psychological distress as a potential 
mediator of the relations.  Analyses 
indicated that distress is higher in more 
socially disordered neighborhoods, that 
distress leads to greater injection 
frequency and equipment sharing, and 
that injection frequency predicts 
equipment sharing. 
Linton et 
al. 2014 105 
Longitudinal 














in the ALIVE 
cohort 
• Neighborhood residential 
rehabilitation, defined as the 
percentage of residential 
properties in the 
participant's neighborhood 
statistical area of residence 
where investment in interior 
or exterior maintenance 
exceeded $5000 USD for a 
given year 
• Injection drug use in 
the past 6 months 
Increased residential rehabilitation was 
associated with decreased injection drug 
use.  When compared to continuous 
residence in neighborhoods with low 
residential rehabilitation, the following 
relocation patterns were associated with 
decreased injection drug use: continuous 
residence in neighborhoods with higher 
residential rehabilitation, relocation 
between neighborhoods with higher 
residential rehabilitation, and relocation 
from neighborhoods with low residential 
rehabilitation to higher residential 
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al. 2014 110 
Cross-
sectional 














in the Urban 
Health Study 
• Activity space distance, 
defined as the distance in 
miles along the street 
network from where a 
participant usually slept, to 
where he hung out during 
the day, to where he used 
drugs in the past 6 months 
• SEP accessibility, defined 
as whether an SEP was 
located within 50 meters of 
the activity space path 
• Receptive or 
distributive syringe 
sharing in the past 6 
months 
Neither activity space distance nor SEP 
accessibility were associated with syringe 
sharing in the past 6 months. 
Nandi et al. 
2010 103 
Longitudinal 










enrolled in the 
ALIVE cohort 
• Neighborhood poverty, 
defined as the percent of 
residents living in poverty in 
the participant's census 
tract of residence 
• Injection cessation, 
defined as abstinence 
from injection drug use 
in the past 6 months 
Analyses conducted using traditional 
regression techniques found no 
significant association between 
neighborhood poverty and injection 
cessation in fully adjusted models.  
However, in analyses that were adjusted 
for confounding using inverse probability 
weights, neighborhood poverty was 
associated with injection cessation.  
Compared with living in a neighborhood 
in the highest category of poverty (>30% 
of residents in poverty), living in a 
neighborhood in the second (>20% but 
≤30%), third (>10% but ≤20%), and 
fourth (≤10%) categories of poverty was 
associated with 20% (AOR=1.20, 1.03-
1.41), 35% (AOR=1.35, 1.12-1.63), and 
44% (AOR=1.44, 1.14-1.82) increased 
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analysis of the 
influence of 
SEP proximity 






776 PWID • Proximity to an SEP site, 
defined as participants' self-
report of the time it would 
take to get to an SEP site 
from "where they usually 
stayed" 
• "Typically" obtained 
needles from SEPs in 
the past 6 months 
• Receptive sharing at 
the last injection 
PWID who reported living within a 10-
minute walk of an SEP site were more 
than 2 times as likely to "typically" obtain 
needles from SEPs in comparison to 
those who lived farther away (AOR=2.89, 
2.06-4.06).  PWID who lived within a 10-
minute walk of an SEP site were also 
less likely to report receptive syringe 
sharing at the last injection (AOR=0.45, 
0.24-0.86). 
Schilling et 
al. 2004 46 
Cross-
sectional 
















• Proximity to an SEP site, 
defined as recruitment into 
the study from the East 
Harlem SEP site, within 10 
blocks of the SEP site, or 
greater than 10 blocks from 
the SEP site 
Injection risk behavior in 
the past 6 months: 
• Used needle after 
others squirted drugs 
into it 
• Shared needles with 
other injectors 
• Used dirty needles by 
yourself 
• Never used new needle 
• Shared same cooker 




• Attended a drug 
treatment program in the 
past 6 months 
• Currently enrolled in a 
drug treatment program 
PWID recruited to the study at the East 
Harlem SEP site were less likely to use a 
needle after others squirted drugs into it 
and to use dirty needles by themselves 
than participants who were recruited from 
the surrounding area.  SEP proximity was 
not associated with the likelihood of 
sharing needles with others, never using 
a new needle, or sharing the same 
cooker. 
 
PWID recruited to the study from within 
10 blocks of the SEP site were more 
likely to report drug treatment in the past 
6 months and current drug treatment 
than those recruited at the SEP site and 
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al. 2004 106 
Longitudinal 









the same area 
of town to buy 






enrolled in the 
SHIELD study 
• Perceived severity of drug 
selling in the neighborhood, 
defined as whether 
participants reported that 
drug selling in their 
neighborhoods was either 
"a problem" or "not a 
problem" 
• Having traveled within the 
same area of town in which 
one lives to buy drugs 
• Injection drug use in 
the past 6 months 
When perceived severity of drug selling 
in the neighborhood and having traveled 
within the same area of town to buy 
drugs were included in the same 
multivariable model, perceived severity of 
drug selling was not associated with 
injection drug use.  However, participants 
who reported traveling within the same 
area of town to buy drugs at baseline 
were more than 4 times as likely to report 
injection drug use at 6-month follow-up in 
comparison to their counterparts who did 
not travel within the same area of town to 
buy drugs (AOR=4.77, 1.62-13.99). 
Stopka et 
al. 2012 111 
Cross-
sectional 















563 PWID • Number of pharmacies 
within a 0.25-mile radius of 




Distance from a 
participant’s intersection to 
the nearest pharmacy 
selling syringes over-the-
counter, measured as: 
• Euclidean distance in 
miles 
• Walking distance in miles 
along the street network 
• Walking time in minutes 
• Pharmacy syringe 
purchase in the past 6 
months 
Euclidean distance, walking distance, 
and walking time to the nearest 
pharmacy selling over-the-counter 
syringes were not associated with 
pharmacy syringe purchase in crude 
models.  As a result, these variables 
were not included in adjusted analyses.  
Number of pharmacies within a 0.25-mile 
radius of the residence was associated 
with pharmacy syringe purchase in a 
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of the data. 
Distance in miles along the 
street network from the 
nearest SEP site to: 
• The participant’s residence 
• The drug buy location 
• The injection location  
 
Path distance in miles from: 
• The residence to the drug 
buy to the injection location 
• The nearest SEP site to 
the residence to the drug 
buy to the injection location 
 
Average distance among: 
• The residence, drug buy, 
and injection locations 
• The nearest SEP, the 
residence, the drug buy, 
and the injection locations 
• Place of most recent 
injection, defined as 
either a public place, a 
shooting gallery, or 
own/family's/friend's 
residence 
• Usual source of 
syringes, defined as 
either an SEP or a non-
SEP 
• Receptive sharing of 
syringes in the past 3 
months 
• Receptive sharing of 
water, cookers, or cotton 
in the past 3 months 
For each 1-mile increase in the distance 
between participants' residences and the 
nearest SEP site, there was a 6% 
increase in the likelihood of using non-
SEP sources for syringe access 
(AOR=1.06, 1.02-1.10). 
 
Blacks were significantly less likely than 
whites to inject in public places as the 
path distance from the residence to drug 
buy location to injection location 
increased (AOR=0.94, 0.90-0.98).  
Latinos were much more likely than 
whites to access syringes from non-SEP 
sources as the distance from the nearest 
SEP to drug buy (AOR=6.70, 2.32-19.4) 
and injection locations (AOR=5.35, 2.53-
11.3) increased.  Latinos were also more 
likely than whites to engage in receptive 
sharing of syringes (AOR=1.21, 1.04-
1.40) and other injection equipment 
(AOR=1.24, 1.03-1.47) as the average 
distance among SEP, residence, drug 







Table 2.2.  Pattern of findings for relations between aspects of the neighborhood context and injection drug use behavior a,b 
Neighborhood characteristic 
Association with injection drug use behavior 
Injection drug use/Injection 
frequency Injection risk behavior c 
Acquisition of syringes from 
SEPs or pharmacies 
Neighborhood socioeconomic characteristics    
Neighborhood socioeconomic disadvantage +
103 +104 +105 M43 042 
 
Neighborhood social disorder +
41 M106 +41 
 
Percent African American  
-42 
 
   
Sterile syringe access    
Spatial access to SEP sites  
-44 -45 M47 060 046 0110 +44 +108 +109 
  
Spatial access to pharmacies selling syringes 
over-the-counter  
M47-49 060 0111 
a Direction of associations identified: + = significant positive association; - = significant negative association; 0 = no association; M = mixed 
results 
b If an association was reported in multiple papers whose analyses utilized the same measures and data, their findings are reported once 
with multiple references. 
c In this table, "injection risk behavior" refers to injection behaviors that increase the risk of BBV transmission, e.g. receptive syringe sharing, 





CHAPTER 3: The influence of neighborhood socioeconomic disadvantage on high-risk injection behavior 




 High-risk injection behaviors, such as syringe sharing and syringe reuse, facilitate the spread of 
HIV, HCV, and other infections among people who inject drugs (PWID).2,3  Research on the determinants 
of high-risk injection behavior has traditionally concentrated on factors operating at the individual level.  
However, evidence gathered over the past twenty years suggests that interventions focused solely on 
individual behavior change will be insufficient to eliminate risky injection practices among PWID.98,99  
More recent work suggests that high-risk injection behavior is shaped not only by individual-level factors, 
but also by the environment in which these behaviors occur.41-47  Several authors have written conceptual 
papers describing how HIV risk is influenced by contextual factors, but the paradigm most often cited is 
that proposed by Rhodes and colleagues in their writings on the risk environment.50,51,53  According to this 
paradigm, the risk environment is the space in which physical, social, political, and economic factors 
exogenous to the individual interact to shape the transmission of blood borne viruses (BBVs) among 
PWID. 
 One element of the risk environment that remains understudied in the context of high-risk 
injection behavior is neighborhood socioeconomic disadvantage.  Neighborhood disadvantage has been 
linked to numerous health conditions and behaviors, ranging from all-cause mortality to smoking;55 
however, the relation between this construct and high-risk injection behavior remains unclear.  To date, at 
least two studies have investigated this association, each yielding different results.  The first, conducted 
among PWID in the San Francisco Bay area, found that census tract-level measures of socioeconomic 
disadvantage were not associated with receptive syringe sharing.42  Conversely, the second found that 
neighborhood-level measures of poverty and educational attainment were associated with high-risk 
injection behavior among inner-city PWID in Montreal, Canada.43  Interestingly, the associations detected 
in the Montreal-based study were in opposite directions.  Poverty was linked to increased high-risk 
injection behavior, while low educational attainment was linked to decreased high-risk injection behavior.  
Together, these results offer conflicting perspectives as to whether neighborhood disadvantage 
influences injection practices, and if so, how.  Equivocal results may be explained, in part, by the fact that 
neighborhood disadvantage may shape high-risk injection behavior through several pathways.  For 
example, poor neighborhoods may have more open drug markets and larger networks of injectors with 
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whom to share syringes, both of which may increase risky injection practices.  However, the same areas 
may also have a higher availability of health and social services geared toward PWID, which may 
decrease high-risk injection behavior. 
 In addition to emphasizing the influence of contextual factors on individual-level behavior among 
PWID, the risk environment paradigm also emphasizes the interplay of these factors in shaping 
outcomes.53  With this in mind, it may be meaningful to examine how neighborhood socioeconomic 
disadvantage operates in the context of other area-level influences on high-risk injection behavior.  
Previous research has identified two area-level characteristics that warrant consideration: syringe 
exchange program (SEP) accessibility and drug-related police activity.  SEPs decrease high-risk injection 
behavior by increasing sterile syringe access and educating PWID on the dangers associated with 
injection equipment sharing.  Studies have shown that the proximity of injectors’ residences to SEP sites 
is associated with increased SEP participation and decreased syringe sharing.44,45,47,108,109  Conversely, 
drug-related police activity has been linked to increased high-risk injection behavior.74,75  This is 
supported by qualitative evidence showing that PWID are afraid of being stopped by police for fear of 
violence and arrest.61-66  Negative encounters with law enforcement may discourage PWID from carrying 
sterile injection equipment and from visiting SEPs and pharmacies to acquire new syringes.66-69  As a 
result, PWID in neighborhoods with high drug-related police activity may be less likely to access sterile 
syringes and practice riskier injection behaviors.  Consistent with this hypothesis, studies conducted in 
Oakland, California; Philadelphia, Pennsylvania; and Vancouver, Canada have all linked police 
crackdowns in high drug use neighborhoods to unsafe injection behaviors and decreased SEP 
attendance.69,71,73 
 To contribute to and clarify the literature about the role of neighborhood environment in the 
etiology of high-risk injection behavior in PWID, we examined relations between common measures of 
neighborhood socioeconomic disadvantage and high-risk injection behavior among a sample of PWID in 
New York City.  In addition, we examined whether associations between neighborhood socioeconomic 






Subjects and setting 
The current analyses use data from the Pharmacists as Resources Making Links to Community 
Services (PHARM-Link) study, which has been described elsewhere.147  Briefly, the PHARM-Link study is 
a pharmacy-randomized intervention trial designed to evaluate the impact of pharmacy-delivered health 
and social service referrals on a variety of outcomes among pharmacy staff and PWID.  Previous studies 
have shown that, in addition to distributing sterile syringes, SEPs are instrumental in linking PWID to 
health and social services, such as HIV testing and drug treatment.  The purpose of PHARM-Link was to 
evaluate the extension of this public health role to pharmacies.   
ESAP-registered pharmacies in high drug activity neighborhoods in New York City were invited to 
participate in the study.  A total of 71 pharmacies were randomized to intervention and primary control 
arms in roughly equal numbers.  Intervention pharmacies offered PWID referrals to health and social 
services via print materials and a drug user-specific web resource guide, while primary control 
pharmacies offered only standard syringe sales services.  PWID were recruited into PHARM-Link when 
visiting study pharmacies to purchase nonprescription syringes.  During syringe transactions with PWID, 
pharmacy staff were trained to discreetly describe the PHARM-Link study and to offer a study 
appointment with research staff within one week of the pharmacy visit.  PWID who were at least 18 years 
of age were eligible to participate.  At the study appointment, research staff obtained informed consent 
and invited participants to complete a 45-minute Audio Computer Assisted Self Interview (ACASI) that 
ascertained data on a variety of topics, including socio-demographic characteristics, drug use history, HIV 
risk behaviors, syringe access and disposal practices, and history of access to medical and social 
services.  Participants were compensated with $20 and a round-trip Metrocard for completion of the 
survey.  Data collection was conducted between March 2009 and October 2010.  The PHARM-Link study 
was approved by the institutional review boards at the New York Academy of Medicine and Columbia 
University.  The current analyses are restricted to participants who reported injection of illicit drugs in the 





High-risk injection behaviors 
The outcomes in this analysis were the following high-risk injection behaviors: unsterile syringe 
use, receptive syringe sharing, and the acquisition of syringes from unsafe sources.  Unsterile syringe 
use includes both receptive syringe sharing and injectors’ reuse of their own syringes.  This behavior was 
measured using the following item: “In the past three months, how often did you use a syringe that you 
were absolutely sure had not been used by anyone, not even yourself?  By this, I mean you heard or 
could feel the cap “snap” when you turned the cap to remove it from the needle?”  Participants were 
asked to respond to this item on a 6-point Likert scale ranging from “Never” to “Always.”  Responses were 
dichotomized so that participants who endorsed any option other than “Always” were considered to have 
engaged in unsterile syringe use.  Similarly, receptive syringe sharing was measured using the following 
item: “In the past three months, how often did you use a syringe that you knew someone had used before 
you?”  Participants were asked to respond to this item on a 6-point Likert scale ranging from “Never” to 
“Always.”  Responses were dichotomized so that participants who endorsed any option other than 
“Never” were considered to have engaged in receptive syringe sharing.  Finally, to assess the acquisition 
of syringes from unsafe sources, participants were asked to report the frequency with which they obtained 
syringes from friends, relatives, syringe dealers, and shooting galleries in the past three months, using a 
7-point Likert scale ranging from “Never” to “Everyday.”  Responses were dichotomized so that 
participants who reported obtaining syringes from any of these sources were categorized as having used 
an unsafe syringe source. 
 
Individual-level covariates 
On the basis of previous research regarding injection risk behavior among PWID, the following 
individual-level covariates were evaluated as potential confounders of associations between 
neighborhood socioeconomic disadvantage and high-risk injection behavior: age (continuous), gender 
(male/female), race (black/Latino/white, other), education (high school graduate, GED/less than high 
school), income (continuous), PHARM-Link randomization group (intervention/primary control), 
homelessness in the past 6 months (yes/no), sexual orientation (gay, lesbian, bisexual/heterosexual), HIV 
status (positive/negative or unknown), and injection frequency (daily/less than daily). 
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Income was measured using two items: 1) “What was your total legal income (on the books) 
before taxes in the past year, this includes public assistance, SSI, etc.?” and 2) “What was your total 
untaxable income (off the books) in the past year?”  Because these items had categorical response 
options, the midpoint of categories selected by participants in response to each item were summed to 
generate a continuous estimate of total income in the past year.  This approach has been used in other 
studies to derive continuous measures of educational attainment and income from categorical data.148 
 
Neighborhood-level measures 
Neighborhood socioeconomic disadvantage 
 Indicators of neighborhood socioeconomic disadvantage were created using census tract-level 
data from the 2006-2010 American Community Survey 5-year estimates.  The American Community 
Survey (ACS) is a nationwide, continuous survey administered by the US Census Bureau to collect data 
on the demographic, housing, social, and economic characteristics of the US population.149,150  To 
generate precise estimates of community characteristics at the census tract-level, the ACS aggregates 
data from five consecutive years, due to the limited population size of most census tracts (typically 
~4,000).151  Estimates are interpreted as the average value of a given characteristic over the time period 
during which the data were collected to produce the estimate.   
Census tract-level ACS data were linked to participants in our sample using data collected on the 
PHARM-Link survey.  Participants were asked to specify “the city and neighborhood you live in” and “the 
cross streets where you spend most of your time.”  Street intersections falling within New York City 
boundaries were geocoded in ArcGIS 10.1, and circular buffers with radii of 0.5 km were drawn around 
each intersection to approximate participants’ neighborhoods.  A 0.5 km-buffer, corresponding to a 10-
minute walking distance, has generally been accepted as a reasonable approximation of the size of the 
local area to which the average neighborhood resident is exposed.43,44,152  Because the area within these 
buffers included parts of multiple census tracts, census-tract level data from the ACS were used in 
conjunction with the area of the census tract parts within each buffer to calculate an area-weighted mean 
for each socioeconomic indicator.  These area-weighted means were used as measures of neighborhood 
disadvantage for each individual in the analysis.  Although many studies on the relation between 
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contextual factors and individual-level outcomes use census tracts as proxies for neighborhood, circular 
buffers centered on specific locations given by study participants may be a more meaningful way to 
represent local environments than administrative units whose boundaries are artificial.115  This may be 
especially true in our sample, given that New York City is a densely populated metropolis in which 
residents are more likely to live near the boundaries of multiple census tracts.   
 The following neighborhood-level factors were considered as exposures of interest: percent of 
residents living in poverty, percent receiving public assistance, percent with low education (defined as the 
percent of residents >25 years of age without a high school diploma or GED), percent >16 years of age 
unemployed, percent residential instability (defined as the percent of residents living in a different house 
than 1 year ago), and an index of neighborhood deprivation.  The neighborhood deprivation index was 
calculated using four census tract-level characteristics abstracted from the 2006-2010 ACS: percent of 
residents living in poverty, percent receiving public assistance, percent >16 years of age unemployed, 
and percent of households that are female-headed.  These variables were standardized to the study 
sample using Z-scores and summed to calculate an index score.  Positive values indicate areas with high 
neighborhood deprivation relative to the sample, while negative values indicate relative affluence.  A 
score of 0 represents neighborhoods with overall values equal to the sample mean.  Indices similar to this 
one have been used in a variety of studies to measure neighborhood socioeconomic disadvantage.153,154 
 
Syringe exchange program accessibility 
 As a measure of SEP accessibility, distances were calculated from street intersections reported 
by PHARM-Link participants to the nearest authorized SEP site.  A list of authorized SEP sites operating 
in New York City in February 2010 was obtained from the New York State Department of Health.  A total 
of 40 SEP sites were geocoded in ArcGIS 10.1, and distances from street intersections to the nearest 
SEP site were calculated along the street network.  Distances were measured in meters and log-
transformed for inclusion in statistical analyses. 
 
Drug-related police activity 
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 As a measure of the intensity of drug-related police activity, the number of drug-related arrests 
per 1000 adult residents was calculated within community districts (named neighborhood units within New 
York City).  Data on the number of drug-related arrests occurring among adults in New York City police 
precincts in 2010 were obtained from the New York State Division of Criminal Justice Services.  Arrests 
were included if the most serious charge was a misdemeanor or felony offense for the possession, sale, 
or use of illicit drugs, drug paraphernalia, or a controlled substance.  Census tract-level data from the 
2010 US Decennial Census were used to calculate the adult population aged ≥ 16 in each police precinct.  
Census tract-level population data were aggregated to the precinct level according to the proportion of 
each census tract’s surface area that lay within each police precinct.  Precinct-level arrest rates per 1000 
adult residents were calculated by dividing the number of drug-related arrests within each precinct by the 
precinct population and multiplying by 1000.  Area-weighted means were used to aggregate precinct-level 
arrest rates to the community district level. 
 
Analytic sample 
A total of 592 participants completed the PHARM-Link survey.  Of these, 61 reported insufficient 
data for geocoding (10.3%), 54 were missing data on one or more individual-level covariates (9.1%), and 
1 was missing data on high-risk injection behavior (0.2%).  Our final analytic sample contained 484 
participants, or 81.7% of the original sample.  Participants excluded for missing data were similar to the 
analytic sample with two exceptions.  Excluded participants were younger than those included in the 
analysis and more likely to report their sexual orientation as gay, lesbian, or bisexual. 
 
Statistical analysis 
Because the PHARM-Link sample was pharmacy-recruited, and our research questions concern 
the influence of neighborhood-level factors on individual-level behaviors, there are at least two ways in 
which our sample can be considered nested: 1) by pharmacy and 2) by neighborhood.  Psuedo-intraclass 
correlation coefficients (ICCs) were used to determine the proportion of variation in our outcomes that 
was explained at the pharmacy and neighborhood levels.  For these analyses, community districts were 
used as proxies for neighborhood. 
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Associations between neighborhood socioeconomic disadvantage and high-risk injection 
behavior were measured using Poisson regression with robust error variance.  These models were 
chosen to account for the high prevalence of outcomes in our analytic sample (23%-49%).  Because odds 
ratios do not approximate risk ratios in the setting of common outcomes, Poisson regression was used to 
estimate risk ratios directly.  Bivariable associations were estimated between all individual- and 
neighborhood-level covariates and high-risk injection behavior.  Individual-level covariates were chosen 
for inclusion in multivariable analyses using a two-tiered approach.  First, analyses were controlled for 
age, gender, race, education, and income.  Second, additional individual-level covariates that were 
associated with any high-risk injection behavior at the p<0.10 level in bivariable analyses were added to 
adjusted models.  Final models were adjusted for age, gender, race, education, income, homelessness, 
sexual orientation, and injection frequency.  Measures of neighborhood socioeconomic disadvantage 
were entered into adjusted models of high-risk injection behavior separately and in continuous form.   
Log of distance to the nearest SEP and drug-related arrest rates were evaluated as potential 
modifiers of associations between neighborhood socioeconomic disadvantage and high-risk injection 
behavior.  Effect modification was assessed by entering cross-product terms for measures of 
neighborhood disadvantage and effect modifiers into adjusted models of high-risk injection behavior.  
Both log of distance to the nearest SEP and drug-related arrest rates were entered into models in 
continuous form.  Additional analyses were carried out to determine whether these variables mediated 
associations between neighborhood disadvantage and high-risk injection behavior.  Detailed methods 




Table 3.1 describes individual-level characteristics of PHARM-Link participants included in this 
analysis.  Characteristics are given for the full sample and stratified by neighborhood socioeconomic 
disadvantage, where high and low groups were created by dichotomizing the neighborhood deprivation 
index at the median.  Participants were 73.1% male with a mean age of 43.5 years.  The racial/ethnic 
composition of the sample differed between neighborhoods of high and low disadvantage.  In low 
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disadvantage neighborhoods, the proportions of Latino (35.1%), black (33.9%), and white (31.0%) 
participants were approximately equal, while in high disadvantage neighborhoods, the sample was 
predominantly Latino (68.6%), with smaller numbers of blacks (19.4%) and whites (12.0%).  Individuals 
from low disadvantage neighborhoods were more likely to report both receptive syringe sharing (26.5% 
vs. 18.6%) and unsterile syringe use (52.1% vs. 46.3%) in the past three months, whereas use of an 
unsafe syringe source was nearly equal across low and high disadvantage groups (27.7% vs. 27.3%). 
 Table 3.2 describes measures of neighborhood socioeconomic disadvantage, SEP accessibility, 
and drug-related police activity for participants in the analytic sample.  As described above, each of these 
measures was created using the street intersection at which participants reported spending most of their 
time.  Street intersections were reported in Manhattan, Bronx, Brooklyn, and Queens.  The range of 
socioeconomic disadvantage represented by neighborhoods surrounding these intersections was 
relatively wide.  The proportion of residents living in poverty, for example, ranged from less than 10% to 
greater than 50% in the analysis sample.  More than half of the study sample reported street intersections 
located within one kilometer of a SEP.  Street intersections also tended to lie within community districts 
whose drug-related arrests rates were higher than the New York City average. 
Table 3.3 shows correlations among the various measures of neighborhood socioeconomic 
disadvantage used in this analysis.  All of these measures were highly positively correlated (ρ ≥ 0.60), 
with the exception of percent residential instability, which was negatively correlated with the other 
measures. 
 Evaluation of pseudo-ICCs revealed that little variation in high-risk injection behavior was 
explained at the pharmacy and community district levels.  Among pharmacies, the pseudo-ICCs for both 
receptive syringe sharing and use of unsafe syringe sources were zero, while that for unsterile syringe 
use was 0.01.  Among community districts, the pseudo-ICC was zero for all high-risk injection behaviors.  
These findings suggest that clustering and autocorrelation of our outcomes, potentially created by the 
PHARM-Link recruitment scheme and by the geographic proximity of participants, were both limited. 
 
Neighborhood socioeconomic disadvantage and high-risk injection behavior 
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 Table 3.4 presents both unadjusted and adjusted associations between measures of 
neighborhood socioeconomic disadvantage and high-risk injection behavior in the past three months.  In 
unadjusted models, the percentage of residents receiving public assistance, percentage unemployed, and 
neighborhood deprivation index were each independently associated with decreased receptive syringe 
sharing.  After the addition of individual-level covariates, these associations remained statistically 
significant.  Marginal inverse associations were also observed for the percentage of residents living in 
poverty (p=0.060) and percentage with low education (p=0.052) in adjusted models of receptive syringe 
sharing. 
 Although measures of neighborhood socioeconomic disadvantage were not significantly 
associated with unsterile syringe use in unadjusted models, the percentage of residents with low 
education, percentage unemployed, and neighborhood deprivation index were all associated with 
decreased unsterile syringe use in adjusted models.  The percentage living in poverty (p=0.058) and 
percentage receiving public assistance (p=0.055) were also marginally associated with decreased 
unsterile syringe use. 
 No statistically significant associations were identified between measures of neighborhood 
socioeconomic disadvantage and the use of unsafe syringe sources. 
 
Effect modification by SEP accessibility and drug-related police activity 
Effect modification was detected between measures of neighborhood socioeconomic 
disadvantage and drug-related police activity in models of unsterile syringe use.  When drug-related 
arrest rates were low (25th percentile), the percentage of residents living in poverty was associated with 
less unsterile syringe use (RR=0.85 per 10% increase in percent poverty).  However, when drug-related 
arrest rates were high (75th percentile), the protective influence of percentage in poverty was attenuated, 
and its association with unsterile syringe use was essentially null (RR=0.98).  The interaction between 
percentage of residents in poverty and drug-related arrests was statistically significant (p=0.0034).  As 
shown in Figure 3.1, similar patterns were observed for the percentage receiving public assistance, 
percentage unemployed, and neighborhood deprivation index. 
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SEP accessibility was also identified as a modifier of associations between measures of 
neighborhood socioeconomic disadvantage and use of unsafe syringe sources.  When distance to the 
nearest SEP was low (25th percentile), the percentage of residents living in poverty was associated with 
less use of unsafe syringe sources (RR=0.87 per 10% increase in percent poverty).  Conversely, when 
distance to the nearest SEP was high (75th percentile), the association changed direction, and the 
percentage of residents in poverty was associated with increased use of unsafe syringe sources 
(RR=1.10).  The cross-product term for percentage of residents in poverty and distance to the nearest 
SEP was statistically significant (p=0.0409).  Similar patterns were observed for percentage receiving 
public assistance, percentage with low education, and neighborhood deprivation index, although not all 
interactions reached statistical significance (Figure 3.2). 
 
Additional analyses 
Both SEP accessibility and drug-related police activity were also investigated as potential 
mediators of relations between neighborhood socioeconomic disadvantage and high-risk injection 
behavior.  Measures of neighborhood socioeconomic disadvantage were associated with shorter 
distances to the nearest SEP and higher drug-related arrest rates.  However, neither of these variables 
was associated with high-risk injection behavior, indicating that SEP accessibility and drug-related police 
activity did not mediate relations between neighborhood socioeconomic disadvantage and high-risk 
injection behavior in our sample.  Detailed results from these analyses are provided in Appendix C. 
 
DISCUSSION 
In this sample of urban PWID in New York City, neighborhood socioeconomic disadvantage was 
associated with safer injection behaviors.  PWID in disadvantaged areas had a lower risk of receptive 
syringe sharing and unsterile syringe use than their counterparts in relatively better off neighborhoods.  A 
closer examination of these results also reveals that neighborhood disadvantage was more strongly 
associated with receptive syringe sharing than with unsterile syringe use.  Given that unsterile syringe 
use includes both receptive syringe sharing and reuse of one’s own syringes, these findings indicate that 
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the inverse association between neighborhood disadvantage and unsterile syringe use was driven 
primarily by decreased receptive syringe sharing (as opposed to decreased syringe reuse). 
Interestingly, the direction of associations among neighborhood disadvantage, receptive syringe 
sharing, and unsterile syringe use were contrary to what we and other authors would predict.50,155  
Hypotheses regarding the influence of neighborhood disadvantage on high-risk injection behavior 
commonly adhere to the premise that poverty is associated with negative health outcomes and behaviors.  
This association has been demonstrated in the context of numerous health conditions,55 and has 
therefore, been assumed to exist for high-risk injection behavior as well.  However, as opposed to finding 
positive associations between neighborhood disadvantage and high-risk injection behavior, our analyses 
found the inverse – neighborhood disadvantage was associated with a lower risk of both receptive 
syringe sharing and unsterile syringe use. 
These results invite us to explore alternative mechanisms linking poverty to health and to 
contemplate how socioeconomically disadvantaged areas may decrease injection risk among PWID.  
One hypothesis is that disadvantaged neighborhoods may have a greater prevalence of HIV prevention 
services, and as a result, PWID in these areas practice safer injection behaviors.  However, our finding 
that distance to the nearest SEP did not mediate associations between neighborhood disadvantage and 
high-risk injection behavior makes this explanation unlikely in our sample.  Another possible explanation 
is injection drug use stigma.  Because injection drug use is likely more common in socioeconomically 
disadvantaged neighborhoods, the stigma associated with this behavior may be lower in poor 
neighborhoods than in those that are relatively better off.  Lower levels of injection drug use stigma may, 
in turn, lead to safer injection practices.  These effects may operate through both structural and 
psychosocial pathways.  For example, in the context of less injection drug use stigma, PWID in poor 
neighborhoods may face fewer barriers to accessing sterile syringes from SEPs and pharmacies.  
Increased syringe access may subsequently lead to decreased receptive syringe sharing.  Alternatively, 
PWID in disadvantaged neighborhoods may experience lower levels of psychosocial stress related to 
their drug use, which may lead them to practice safer injection behaviors.  Future research on the effects 
of injection drug use stigma should consider its role in mediating the influence of neighborhood 
disadvantage on high-risk injection behavior. 
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 The analyses presented above also found that the protective influence of neighborhood 
disadvantage against unsterile syringe use was attenuated by drug-related police activity.  Similar 
relations between neighborhood disadvantage and receptive syringe sharing were not modified by drug-
related arrest rates, indicating that modification effects on unsterile syringe use were attributable to 
increased reuse of injectors’ own syringes.  Together, these results suggest that drug-related police 
activity is a barrier to sterile syringe access among PWID.  Injectors who are deterred from acquiring new 
syringes at SEPs or pharmacies by a fear of police encounters may compensate for decreased syringe 
access by reusing their injection equipment.  These findings are not surprising, given the wealth of 
research linking drug-related police activity to decreases in SEP attendance and increases in injection 
risk behavior.69-71,73-75  However, the absence of a similar modification effect on receptive syringe sharing 
is unexpected.  Previous studies in San Francisco and Los Angeles have specifically linked fear of arrest 
to increased syringe sharing.75,156  The finding that PWID in our sample may compensate for decreased 
syringe access in areas with high drug-related arrest rates through syringe reuse as opposed to receptive 
syringe sharing may be a testament to the effectiveness of HIV prevention efforts in New York City.  
Although syringe reuse places PWID at risk of infections including abscesses, cellulitis, and endocarditis, 
it may be considered a somewhat lower risk activity than receptive syringe sharing, which facilitates the 
spread of BBVs, such as HIV and HCV.2-5  
 Effect modification was also detected between neighborhood socioeconomic disadvantage and 
distance to the nearest SEP in models of the use of unsafe syringe sources.  Relations between 
neighborhood disadvantage and the use of unsafe syringe sources were likely null in main effect models 
because these associations reversed direction as distance to the nearest SEP increased (Figure 3.2).  
Among PWID who spent time close to an SEP site, neighborhood disadvantage was associated with 
decreased use of unsafe syringe sources.  However, as distance to the nearest SEP site increased, 
neighborhood disadvantage became associated with increased use of unsafe syringe sources.  These 
results suggest the importance of SEPs as alternatives to unsafe syringe sources.  In the absence of 
SEPs, and therefore more restricted access to sterile syringes, neighborhood disadvantage may increase 
syringe acquisition from unsafe sources through a number of pathways.  Disadvantaged neighborhoods 
may have a higher availability of syringes from unsafe sources, including syringe dealers and open drug 
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markets.  In addition, because injection drug use is likely more common in disadvantaged neighborhoods, 
these areas may also contain larger, denser networks of PWID.  Previous research regarding the 
influence of social networks on injection practices has shown that network size and density are positively 
associated with high-risk injection behavior.56  Conversely, in neighborhoods containing SEPs, the 
protective influence of socioeconomic disadvantage, which we observed in the context of receptive 
syringe sharing and unsterile syringe use, was observed for the use of unsafe syringe sources as well.  
This result is consistent with previous work linking SEP proximity to increased SEP participation.44,108,109 
 The findings from this study should be considered in light of a number of limitations.  First, our 
data are cross-sectional, which prevents us from establishing the causality of relations between 
neighborhood socioeconomic disadvantage and high-risk injection behavior.  Present-day risk behaviors 
are likely influenced by socioeconomic contexts experienced in the past, which we are unable to capture 
using a cross-sectional design.  This is a common limitation of analyses investigating neighborhood-level 
characteristics due to the difficulty of studying neighborhoods longitudinally.  Second, self-reported data 
were used to create measures of high-risk injection behavior.  Although this approach introduces the 
possibility of bias, previous studies have shown that self-reported measures of injection risk behavior are 
accurate and reliable.157  Third, our measures of SEP accessibility and drug-related police activity may 
have been subject to misclassification issues.  Distance to the nearest SEP was calculated using the 
locations of New York State-registered SEP sites as of February 2010.  As a result, this measure did not 
account for SEP sites that opened and closed during the data collection period, illegal SEP sites, or 
secondary syringe exchange.  With regard to drug-related arrest rates, the smallest geographic units for 
which arrest data were available were police precincts.  Measures of drug-related police activity on a 
smaller spatial scale may have been more appropriate for studying the influence of law enforcement on 
individual-level behavior.  Although measures of SEP accessibility and drug-related police activity were 
imperfect, statistically significant interactions were identified between both of these variables and 
neighborhood socioeconomic disadvantage.  These results indicate that both constructs were sufficiently 
captured by the measures used.  Fourth, the findings from our study may have limited external validity.  
Participants in our sample were recruited while purchasing syringes from pharmacies, which suggests 
that they may engage in fewer high-risk injection behaviors than PWID in the general population who do 
 
 62
not use safe syringe sources.  In addition, our study was conducted in New York City, where syringe 
availability is high and HIV prevention services are extensive in comparison to other parts of the US.  
Taken together, these circumstances indicate that the findings from our analyses are not broadly 
generalizable.  However, the sale of non-prescription syringes has been legalized in several states, 
creating new populations of pharmacy-using PWID across the country.  Understanding the influence of 
neighborhood context on patterns of risk behavior in this group will continue to be important.  
Furthermore, as harm reduction approaches to addressing injection drug use become more 
commonplace, populations of PWID in urban areas will more closely resemble those in New York City. 
In this study, we sought to explore how one aspect of the neighborhood context – socioeconomic 
disadvantage – influences high-risk injection behavior.  Our results highlight the importance of the risk 
environment in shaping injection behavior and BBV transmission among PWID.  Not only was 
neighborhood-level disadvantage associated with decreased receptive syringe sharing and unsterile 
syringe use, but relations with unsterile syringe use and the use of unsafe syringe sources were modified 
by other area-level phenomena – SEP accessibility and drug-related police activity.  These results have 
numerous implications for both research and policy.  Future studies could attempt to identify 
characteristics of disadvantaged neighborhoods that decrease the likelihood of certain high-risk injection 
behaviors.  Given the common perception of disadvantaged neighborhoods as high-risk environments, 
this is a potentially fruitful, and as yet, unexplored avenue of inquiry.  In addition, new research could also 
examine the role of neighborhood disadvantage in shaping other behaviors that facilitate BBV 
transmission, such as the sharing of other injection paraphernalia (e.g. cotton, cookers, water).  With 
respect to policy, our findings regarding effect modification provide further evidence of the benefits of 
SEPs and the harms of police activity in the context of injection risk behavior.  Together, these results are 
consistent with prior recommendations that injection drug use be addressed using approaches geared 
toward harm reduction as opposed to law enforcement.   
Overall, research on the influence of neighborhood-level factors on injection drug use is still in its 
nascent stages.  Additional studies are needed to investigate how aspects of the risk environment and 
their interplay influence individual-level behavior.  A better understanding of these relations will be 





CHAPTER 3 TABLES AND FIGURES 










    No. (%) or Mean (SD)  
Age 
 
43.5 (9.3) 43.9 (9.9) 43.1 (8.7) 0.38 
Male 354 (73.1%) 178 (73.6%) 176 (72.7%) 0.84 
Race/ethnicity       <.0001c 
 
Hispanic/Latino (regardless of race) 251 (51.9%) 85 (35.1%) 166 (68.6%) 
 Non-Hispanic Black 129 (26.7%) 82 (33.9%) 47 (19.4%) 
 Non-Hispanic White and other 104 (21.5%) 75 (31.0%) 29 (12.0%) 
 Less than high school diploma/GED 179 (37.0%) 86 (35.5%) 93 (38.4%) 0.51 
Income in the past year 8951 (10412) 9556 (11219) 8347 (9522) 0.20 
Homeless in the past 6 months 162 (33.5%) 88 (36.4%) 74 (30.6%) 0.18 
Gay, lesbian, or bisexual 52 (10.7%) 28 (11.6%) 24 (9.9%) 0.56 
Injected daily in the past 3 months 167 (34.5%) 77 (31.8%) 90 (37.2%) 0.21 
HIV positive 63 (13.0%) 16 (6.6%) 47 (19.6%) <.0001c 
PHARM-Link intervention group 225 (46.5%) 130 (53.7%) 95 (39.3%) 0.0014c 
 
      
 High-risk injection behaviors (in the past 3 months)       
 Receptive syringe sharing 109 (22.5%) 64 (26.5%) 45 (18.6%) 0.04c 
 
Unsterile syringe use 238 (49.2%) 126 (52.1%) 112 (46.3%) 0.20 
  Use of unsafe syringe source 133 (27.5%) 67 (27.7%) 66 (27.3%) 0.92 
a Low and high neighborhood disadvantage groups were created by dichotomizing the neighborhood deprivation index at the median.  Low 
neighborhood disadvantage = neighborhood deprivation index < 0.3, High neighborhood disadvantage = neighborhood deprivation index ≥ 
0.3. 
b p-value for comparison of low and high neighborhood disadvantage groups.  p-values are from t-tests for continuous variables and Chi-
square tests for categorical variables. 






Table 3.2  Characteristics of geographic areas surrounding street intersections reported by PHARM-Link study participants (N=484) 













 % poverty 31.3 (10.0) 4.0 26.2 30.3 40.0 50.7 
 
% public assistance 8.0 (3.9) 0.2 5.4 7.4 11.3 15.5 
 
% low education 30.9 (12.0) 1.8 21.4 33.3 40.7 51.0 
 
% unemployed 12.7 (4.2) 3.4 9.7 12.8 15.6 21.5 
 
% residential instability 12.7 (4.9) 3.9 9.4 11.8 14.8 32.6 
 







 Distance to the nearest SEP (m) 1161 (1153) 5 413 861 1423 8233 
Log of distance to the nearest SEP 6.7 (1.0) 1.6 6.0 6.8 7.3 9.0 









Table 3.3  Correlations among indicators of neighborhood socioeconomic disadvantage measured for PHARM-Link participants (N=484) 










% poverty 1 
 % public assistance 0.90 1 
 % low education 0.79 0.81 1 
 % unemployed 0.75 0.73 0.60 1 
 % residential instability -0.34 -0.33 -0.29 -0.21 1 






Table 3.4  Unadjusted and adjusted associations between indicators of neighborhood socioeconomic disadvantage and high-risk injection behavior among 
PHARM-Link study participants (N=484) 
  Receptive syringe sharing Unsterile syringe use Use of unsafe syringe source 
  












% poverty 0.86 (0.73, 1.02) 0.84 (0.70, 1.01) 0.93 (0.85, 1.01) 0.91 (0.83, 1.00) 0.97 (0.85, 1.11) 0.98 (0.84, 1.14) 
% public assistance 0.60 (0.40, 0.90)a 0.56 (0.36, 0.88)a 0.81 (0.65, 1.02) 0.78 (0.61, 1.00) 0.88 (0.62, 1.25) 0.91 (0.63, 1.32) 
% low education 0.89 (0.78, 1.02) 0.87 (0.75, 1.00) 0.94 (0.87, 1.01) 0.92 (0.85, 0.98)a 0.98 (0.87, 1.11) 0.99 (0.86, 1.13) 
% unemployed 0.62 (0.41, 0.93)a 0.56 (0.37, 0.86)a 0.81 (0.65, 1.01) 0.79 (0.63, 0.99)a 0.84 (0.60, 1.17) 0.77 (0.53, 1.10) 
% residential instability 0.98 (0.69, 1.41) 0.96 (0.67, 1.38) 1.01 (0.84, 1.22) 1.02 (0.85, 1.23) 0.96 (0.70, 1.32) 0.94 (0.69, 1.29) 
Neighborhood deprivation 
index 
0.82 (0.69, 0.98)a 0.79 (0.65, 0.96)a 0.91 (0.83, 1.01) 0.89 (0.81, 0.99)a 0.94 (0.81, 1.09) 0.93 (0.79, 1.10) 
a p < 0.05 
Note: Values shown are risk ratios and 95% confidence intervals for 10% increases (e.g. 10% to 20%) in indicators of neighborhood socioeconomic 
disadvantage, with the exception of neighborhood deprivation index.  For neighborhood deprivation index, risk ratios were estimated for 4-unit increases.  
Adjusted models were controlled for the following individual-level confounders: age, gender, race, education, income, homelessness, sexual orientation, 





   
 






Figure 3.1.  Effect modification of associations between indicators of neighborhood socioeconomic disadvantage and 
unsterile syringe use by drug-related police activity.  Predicted probabilities of unsterile syringe use were estimated 
when drug-related arrest rates per 1000 adults were fixed at the 25th percentile (low drug-related police activity) and 
the 75th percentile (high drug-related police activity).  Models were adjusted for the following individual-level 
confounders: age, gender, race, education, income, homelessness, sexual orientation, and injection frequency.  
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Figure 3.2.  Effect modification of associations between indicators of neighborhood socioeconomic disadvantage and 
the use of unsafe syringe sources by SEP accessibility.  Predicted probabilities of the use of unsafe syringe sources 
were estimated when distance to the nearest SEP was fixed at the 25th percentile (high SEP accessibility) and the 
75th percentile (low SEP accessibility).  Models were adjusted for the following individual-level confounders: age, 
gender, race, education, income, homelessness, sexual orientation, and injection frequency.  Interaction p-values are 
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CHAPTER 4: The influence of social discomfort surrounding the acquisition of sterile syringes on high-risk 




In an effort to increase sterile syringe access among people who inject drugs (PWID), many US 
states have legalized both syringe exchange programs (SEPs) and the sale of non-prescription syringes 
from pharmacies.  However, despite these interventions, PWID continue to practice injection behaviors 
that increase their risk of acquiring blood borne viruses (BBVs).  In 2012, an estimated 30% of HIV-
negative PWID engaged in receptive syringe sharing, while 55% used contaminated injection equipment.7  
Identifying facilitators and barriers to the utilization of safe syringe sources is necessary to reduce high-
risk injection behavior and to eliminate the transmission of BBVs among PWID. 
One potential obstacle to sterile syringe access among PWID is the lack of comfort that many 
injectors experience when entering SEPs and pharmacies to acquire syringes.  Pharmacies, in particular, 
have emerged as intimidating environments for PWID to navigate.61,62,76-78  Injectors have reported a fear 
of being identified as PWID by pharmacy staff, and being treated poorly as a result.79,80  Both unfriendly 
attitudes and judgmental treatment on the part of pharmacists and other patrons have been cited as 
obstacles to pharmacy syringe purchases.62,77,81  In addition, some pharmacists may refuse to sell 
syringes to PWID or question them about the intended use of syringes.61,76,79,82  Feelings of discomfort 
may be exacerbated by injectors’ fear that pharmacy staff and patrons who become aware of their 
injection drug use may share this information with other members of the community.76,78,81  Although 
PWID have expressed similar concerns surrounding the use of SEPs,65,78,83 experiences with SEP staff 
are often described in positive terms.61,76,84  Qualitative data indicate that SEP staff make their clients feel 
as though they are acknowledged and that they have value.84 
 The lack of comfort reported by PWID during visits to SEPs and pharmacies (hereafter referred to 
as social discomfort) may be attributable to injection drug use stigma.76-78  Negative attitudes toward drug 
use and drug injection are widespread in today’s society, making PWID a highly stigmatized population.  
The social discomfort experienced by members of this group as a consequence of injection drug use 
stigma may discourage them from frequenting safe syringe sources to acquire sterile injection equipment.  
As a result, they may be more likely to engage in high-risk injection behaviors, such as receptive syringe 
sharing, syringe reuse, and the acquisition of syringes from unsafe sources.  No studies, of which we are 
aware, have investigated associations between social discomfort and high-risk injection behavior.  
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However, previous work supports the existence of a relation between these constructs.  Among a sample 
of PWID in Chennai, India, Latkin and colleagues found that drug use stigma was associated with 
increased syringe sharing.89  One explanation for these findings is that social discomfort brought about by 
drug use stigma posed a barrier to sterile syringe access.  In addition, among a sample of PWID in New 
York City, Rivera and colleagues found that higher levels of injection drug use stigma were associated 
with not acquiring syringes from either SEPs or pharmacies in the past three months.143  Again, social 
discomfort is a potential mediator of this association.  Further studies have shown that stigma is a 
powerful barrier to accessing health services in the setting of several health conditions, including HIV,91 
depression,144 and obesity.145 
 Because social discomfort is likely a product of social interactions, its influence on high-risk 
injection behavior may also vary by social context.  Given the concentration of drug markets and PWID in 
poor areas, it may be meaningful to consider whether social discomfort operates differentially in 
neighborhoods with varying levels of socioeconomic disadvantage.  Disadvantaged neighborhoods may 
be characterized by higher levels of drug-related police activity, greater availability of syringes from 
unsafe sources, and larger, denser networks of PWID.  Together, these attributes may enhance the 
negative influence of social discomfort on high-risk injection behavior.  However, it is also possible that 
disadvantage has the reverse effect.  In poor neighborhoods, where injection drug use may be more 
common, PWID may be less stigmatized.  Injectors in disadvantaged areas may experience greater social 
support in the community, which may serve to buffer increases in high-risk injection behavior brought 
about by social discomfort. 
 In this study, we sought to investigate the influence of social discomfort on high-risk injection 
behavior by measuring associations between these constructs among a sample of PWID in New York 
City.  Furthermore, we examined whether associations between measures of social discomfort and high-
risk injection behavior were modified by neighborhood socioeconomic disadvantage. 
 
METHODS 
Subjects and setting 
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The current analyses use data from the Pharmacists as Resources Making Links to Community 
Services (PHARM-Link) study, which has been described elsewhere.147  Briefly, the PHARM-Link study is 
a pharmacy-randomized intervention trial designed to evaluate the impact of pharmacy-delivered health 
and social service referrals on a variety of outcomes among pharmacy staff and PWID.  Previous studies 
have shown that, in addition to distributing sterile syringes, SEPs are instrumental in linking PWID to 
health and social services, such as HIV testing and drug treatment.  The purpose of PHARM-Link was to 
evaluate the extension of this public health role to pharmacies.   
Pharmacies in high drug activity neighborhoods in New York City, which were registered to sell 
sterile syringes through New York State’s Expanded Syringe Access Program (ESAP), were invited to 
participate in the study.  A total of 71 pharmacies were randomized to intervention and primary control 
arms in roughly equal numbers.  Intervention pharmacies offered PWID referrals to health and social 
services via print materials and a drug user-specific web resource guide, while primary control 
pharmacies offered only standard syringe sales services.  PWID were recruited into PHARM-Link when 
visiting study pharmacies to purchase nonprescription syringes.  During syringe transactions with PWID, 
pharmacy staff were trained to discreetly describe the PHARM-Link study and to offer a study 
appointment with research staff within one week of the pharmacy visit.  PWID who were at least 18 years 
of age were eligible to participate.  At the study appointment, PWID were invited to complete a 45-minute 
Audio Computer Assisted Self Interview (ACASI) that ascertained data on a variety of topics, including 
socio-demographic characteristics, drug use history, HIV risk behaviors, syringe access and disposal 
practices, and history of access to medical and social services.  Participants were compensated with $20 
and a round-trip Metrocard for completion of the survey.  Data collection was conducted between March 
2009 and October 2010.  The PHARM-Link study was approved by the institutional review boards at the 
New York Academy of Medicine and Columbia University.  The current analyses are restricted to 
participants who reported injection of illicit drugs in the three months prior to interview. 
 
Measures 
High-risk injection behaviors 
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The outcomes in this analysis were the following high-risk injection behaviors: unsterile syringe 
use, receptive syringe sharing, and the acquisition of syringes from unsafe sources.  Unsterile syringe 
use includes both receptive syringe sharing and injectors’ reuse of their own syringes.  This behavior was 
measured using the following item: “In the past three months, how often did you use a syringe that you 
were absolutely sure had not been used by anyone, not even yourself?  By this, I mean you heard or 
could feel the cap “snap” when you turned the cap to remove it from the needle?”  Participants were 
asked to respond to this item on a 6-point Likert scale ranging from “Never” to “Always.”  Responses were 
dichotomized so that participants who endorsed any option other than “Always” were considered to have 
engaged in unsterile syringe use.  Similarly, receptive syringe sharing was measured using the following 
item: “In the past three months, how often did you use a syringe that you knew someone had used before 
you?”  Participants were asked to respond to this item on a 6-point Likert scale ranging from “Never” to 
“Always.”  Responses were dichotomized so that participants who endorsed any option other than 
“Never” were considered to have engaged in receptive syringe sharing.  Finally, to assess the acquisition 
of syringes from unsafe sources, participants were asked to report the frequency with which they obtained 
syringes from friends, relatives, syringe dealers, and shooting galleries in the past three months, using a 
7-point Likert scale ranging from “Never” to “Everyday.”  Responses were dichotomized so that 
participants who reported obtaining syringes from any of these sources were categorized as having used 
an unsafe syringe source. 
 
Social discomfort surrounding the acquisition of sterile syringes 
Social discomfort surrounding the acquisition of sterile syringes from pharmacies and SEPs was 
measured using five items from the PHARM-Link survey.  Participants were asked to indicate their level of 
agreement with the following items on a 4-point Likert scale ranging from “Strongly agree” to “Strongly 
disagree”: 1) It doesn’t matter to me if people know why I’m buying syringes when I’m in line at the 
pharmacy, 2) I feel comfortable trying to buy a syringe at any pharmacy even if I don’t know if they’ll sell 
to me before I go in the store, 3) It wouldn’t matter to me if people saw me walk into a syringe exchange 
program, 4) Pharmacists care about my health and well-being, and 5) The staff at syringe exchange 
programs seems to care about my health and well-being.  The response format for each of these items 
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was recoded to a numeric scale ranging from 0 to 3, where higher scores were indicative of greater 
disagreement with the items, and therefore, greater social discomfort.  These items were entered into 
analyses individually as continuous variables.   
 In addition to examining each item individually, the scores from the first three items listed above 
were combined in a simple sum to create a social discomfort score (range: 0-9).  Although exploratory 
factor analyses revealed that all five items loaded onto a single factor, the items pertaining to pharmacists 
and SEP staff may reflect a different dimension of social discomfort, and for this reason, were not 
included in the sum score.  Exploratory factor analyses limited to the first three items showed that they 
loaded strongly on a single factor, with loadings >0.60 for each item.  The social discomfort score was 
entered into analyses as a continuous variable (α=0.62). 
 
Neighborhood socioeconomic disadvantage 
 Neighborhood socioeconomic disadvantage was measured using an index comprised of four 
census tract-level characteristics: percent of residents living in poverty, percent receiving public 
assistance, percent >16 years of age unemployed, and percent of households that are female-headed.  
Census tract-level data were abstracted from the 2006-2010 American Community Survey 5-year 
estimates.  The American Community Survey (ACS) is a nationwide, continuous survey administered by 
the US Census Bureau to collect data on the demographic, housing, social, and economic characteristics 
of the US population.149,150  To generate precise estimates of community characteristics at the census 
tract-level, the ACS aggregates data from five consecutive years, due to the limited population size of 
most census tracts (typically ~4,000).151  Estimates are interpreted as the average value of a given 
characteristic over the time period during which the data were collected to produce the estimate.   
Census tract-level ACS data were linked to participants in our sample using items on the 
PHARM-Link survey.  Participants were asked to specify “the city and neighborhood you live in” and “the 
cross streets where you spend most of your time.”  Street intersections falling within New York City 
boundaries were geocoded in ArcGIS 10.1, and circular buffers with radii of 0.5 km were drawn around 
each intersection to approximate participants’ neighborhoods.  Because the area within these buffers 
included parts of multiple census tracts, census-tract level data from the ACS were used in conjunction 
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with the area of the census tract parts within each buffer to calculate an area-weighted mean for each 
characteristic included in the neighborhood deprivation index.  These area-weighted means were 
standardized to the study sample using Z-scores and summed to create an index score.  Positive values 
indicate areas with high neighborhood deprivation relative to the sample, while negative values indicate 
relative affluence.  A score of 0 represents neighborhoods with overall values equal to the sample mean.   
Although many studies on the relation between contextual factors and individual-level outcomes 
use census tracts as proxies for neighborhood, circular buffers centered on specific locations given by 
study participants may be a more meaningful way to represent local environments than administrative 
units, whose boundaries are artificial.115  Buffers with radii of 0.5 km, which we used in this study, have 
generally been accepted as reasonable approximations of the size of the local area to which the average 
neighborhood resident is exposed.43,44,152  Indices containing census tract-level characteristics similar to 




On the basis of previous research regarding injection risk behavior among PWID, the following 
individual-level covariates were evaluated as potential confounders of associations between social 
discomfort surrounding the acquisition of sterile syringes and high-risk injection behavior: age 
(continuous), gender (male/female), race (black/Latino/white, other), education (high school graduate, 
GED/less than high school), income (continuous), PHARM-Link randomization group (intervention/primary 
control), homelessness in the past 6 months (yes/no), sexual orientation (gay, lesbian, 
bisexual/heterosexual), HIV status (positive/negative or unknown), injection frequency (daily/less than 
daily), drug treatment in the past 3 months (yes/no), ever harassed by police at SEPs or pharmacies 
(yes/no), and SEP use in the past 3 months (yes/no). 
Income was measured using two items: 1) “What was your total legal income (on the books) 
before taxes in the past year, this includes public assistance, SSI, etc.?” and 2) “What was your total 
untaxable income (off the books) in the past year?”  Because these items had categorical response 
options, the midpoint of categories selected by participants in response to each item were summed to 
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generate a continuous estimate of total income in the past year.  This approach has been used in other 
studies to derive continuous measures of education and income from categorical data.148 
 
Analytic sample 
A total of 592 participants completed the PHARM-Link survey.  Of these, 61 reported insufficient 
data for geocoding (10.3%), 34 were missing data on a social discomfort item (5.7%), 20 were missing 
data on one or more individual-level covariates (3.4%), and 1 was missing data on high-risk injection 
behavior (0.2%).  Our final analytic sample contained 484 participants, or 81.7% of the original sample.  
Participants excluded for missing data were similar to the analytic sample on all variables with three 
exceptions.  Excluded participants were younger than those included in the analysis, more likely to report 




Because the PHARM-Link sample was pharmacy-recruited, and our analysis examines a 
neighborhood-level factor as an effect modifier, there are at least two ways in which our sample can be 
considered nested: 1) by pharmacy and 2) by neighborhood.  Psuedo-intraclass correlation coefficients 
were used to determine the proportion of variation in our outcomes that was explained at the pharmacy 
and neighborhood levels.  For these analyses, community districts were used as proxies for 
neighborhood. 
Associations between social discomfort surrounding the acquisition of sterile syringes and high-
risk injection behavior were measured using Poisson regression with robust error variance.  These 
models were chosen to account for the high prevalence of outcomes in our analytic sample (23%-49%).  
Because odds ratios do not approximate risk ratios in the setting of common outcomes, Poisson 
regression was used to estimate risk ratios directly.  Bivariable associations were estimated between all 
individual- and neighborhood-level covariates and high-risk injection behavior.  Individual-level covariates 
were chosen for inclusion in multivariable analyses using a two-tiered approach.  First, analyses were 
controlled for age, gender, race, education, and income.  Second, additional individual-level covariates 
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that were associated with any high-risk injection behavior at the p<0.10 level in bivariable analyses were 
added to adjusted models.  Final models were adjusted for age, gender, race, education, income, 
homelessness, sexual orientation, injection frequency, and ever harassed by police at SEPs or 
pharmacies. 
Neighborhood socioeconomic disadvantage was evaluated as a potential modifier of associations 
between social discomfort and high-risk injection behavior.  Effect modification was assessed by entering 
cross-product terms for social discomfort items and the neighborhood deprivation index into adjusted 
models of high-risk injection behavior.  Cross-product terms were assessed for statistical significance; 
however, because our analyses were underpowered to detect interactions, cross-product terms were 
deemed significant when p<0.10.  This cut-point has been used in several other observational studies 
seeking to identify social determinants of health outcomes.48,158-160  Neighborhood deprivation index was 




 Table 4.1 provides descriptive statistics of PHARM-Link participants included in this analysis.  
Characteristics are given for both the full sample and stratified by social discomfort surrounding the 
acquisition of sterile syringes, where high and low groups were created by dichotomizing the social 
discomfort score at the median.  Participants were 73.1% male with a mean age of 43.5 years.  The 
sample was 51.9% Latino, 26.7% black, and 21.5% white.  Reports of high-risk injection behavior in the 
past three months were relatively common, with 22.5% of participants reporting receptive syringe sharing, 
49.2% reporting unsterile syringe use, and 27.5% reporting use of an unsafe syringe source.  Levels of 
neighborhood socioeconomic disadvantage were similar across high and low levels of social discomfort. 
Table 4.2 describes the items used to measure social discomfort in this analysis.  The mean level 
of discomfort reported by participants was similar for all items with the exception of “The staff at syringe 
exchange programs seems to care about my health and well-being.”  For this item, the mean score was 
0.85, while that of the other items ranged from 1.17 to 1.25. 
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 Evaluation of pseudo-ICCs revealed that little variation in high-risk injection behavior was 
explained at the pharmacy and community district levels.  Among pharmacies, the pseudo-ICCs for both 
receptive syringe sharing and use of unsafe syringe sources were zero, while that for unsterile syringe 
use was 0.01.  Among community districts, the pseudo-ICC was zero for all high-risk injection behaviors.  
These findings suggest that clustering and autocorrelation of our outcomes, potentially created by the 
PHARM-Link recruitment scheme and by the geographic proximity of participants, were both limited. 
 
Social discomfort surrounding the acquisition of sterile syringes and high-risk injection behavior 
 Table 4.3 presents associations between measures of social discomfort and high-risk injection 
behavior in the past three months.  No statistically significant associations were observed between 
measures of social discomfort and receptive syringe sharing or unsterile syringe use in unadjusted or 
adjusted models.  However, the following item was positively associated with the use of unsafe syringe 
sources in both unadjusted and adjusted analyses: “The staff at syringe exchange programs seems to 
care about my health and well-being.”  For every 1-unit increase in score on this item (indicative of 
greater disagreement), participants were 27% more likely to report using an unsafe syringe source, after 
controlling for individual-level covariates (RR=1.27, 1.05-1.52). 
 
Effect modification by neighborhood socioeconomic disadvantage 
 Neighborhood socioeconomic disadvantage was identified as a modifier of the association 
between “Pharmacists care about my health and well-being” and receptive syringe sharing (Figure 4.1).  
When neighborhood socioeconomic disadvantage was low (25th percentile), increasing disagreement with 
the item pertaining to pharmacists was associated with decreased receptive syringe sharing (RR=0.82 
per 1-unit increase in item score).  However, when neighborhood socioeconomic disadvantage was high 
(75th percentile), increasing disagreement was associated with increased receptive syringe sharing 
(RR=1.16).  The cross-product term for “Pharmacists care about my health and well-being” and 
neighborhood socioeconomic disadvantage was statistically significant (p=0.004).   
Similarly, neighborhood socioeconomic disadvantage also modified associations between “The 
staff at syringe exchange programs seems to care about my health and well-being” and receptive syringe 
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sharing (Figure 4.1).  The magnitude and direction of interaction effects were nearly identical to those 
observed for the item pertaining to pharmacists.  Disagreement with the SEP staff item was positively 
associated with receptive syringe sharing when neighborhood disadvantage was high (RR=1.15) and 
inversely associated with receptive syringe sharing when neighborhood disadvantage was low (RR=0.86).  
Again, these trends were statistically significant (p=0.0793).   
 
DISCUSSION 
 In this sample of urban PWID, indicators of social discomfort surrounding the acquisition of sterile 
syringes were not associated with high-risk injection behavior.  The only exception was the item 
pertaining to SEP staff: “The staff at syringe exchange programs seems to care about my health and well-
being.”  Participants who disagreed with this statement were more likely to have used an unsafe syringe 
source in the past three months.  Although this result may be a spurious finding attributable to the number 
of comparisons performed, it is consistent with previous qualitative work on the opinions of PWID toward 
SEP staff.  While many PWID tend to fear being stigmatized by pharmacy staff during syringe purchases, 
SEP staff are often described as non-judgmental, helpful, and supportive.64,76,78,83,84  PWID in our sample 
appeared to view SEP staff in a similar fashion, reporting the most positive attitudes in response to the 
SEP staff item (Table 4.2).  Considering these findings, it is possible that those who disagreed with the 
SEP staff item were those who experienced the highest levels of discomfort surrounding the acquisition of 
sterile syringes at pharmacies and SEPs.  As a result, this item may have been a stronger indicator of 
social discomfort than the others and was found to be associated with the use of unsafe syringe sources, 
while all other associations were null.  Participants who disagreed with the SEP staff item may have been 
deterred from using safe syringe sources by social discomfort, making them more likely to seek syringes 
from unsafe sources. 
 Overall, the lack of associations observed between indicators of social discomfort and high-risk 
injection behavior may be explained by the manner in which our sample was recruited.  PWID were 
invited to participate in the PHARM-Link study while visiting pharmacies to purchase sterile syringes.  
Given this recruitment scheme, we can make two inferences about the PWID in our sample.  First, the 
level of social discomfort among our study participants was likely lower than that among the general 
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population of PWID.  Injectors who enrolled in our study not only felt comfortable enough to seek syringes 
from safe sources, but they also felt comfortable doing so at pharmacies, which according to the 
qualitative literature is a particularly stigmatizing environment for PWID.  Second, because study 
participants were recruited while accessing syringes from safe sources, levels of high-risk injection 
behavior are likely lower in this group than among the general population of PWID.  Taken together, these 
inferences suggest that our study sample may be missing PWID who practice high-risk injection 
behaviors and who have high levels of social discomfort surrounding the acquisition of sterile syringes.  
The absence of these PWID from our sample would have biased associations between social discomfort 
and high-risk injection behavior toward the null.  Future studies on this topic should use community-
recruited samples of PWID that include injectors who do not use safe syringe sources or who do so 
infrequently.  Because we are interested in understanding whether social discomfort is a barrier to sterile 
syringe access, this approach may enhance the likelihood of identifying links between social discomfort 
and high-risk injection behavior. 
 Evaluation of neighborhood socioeconomic disadvantage as a potential modifier of relations 
between social discomfort and high-risk injection behavior returned a number of intriguing results.  Effect 
modification was detected in models of receptive syringe sharing for the following items: “Pharmacists 
care about my health and well-being” and “The staff at syringe exchange programs seems to care about 
my health and well-being.”  Interestingly, the magnitude and direction of interaction effects across these 
items was nearly identical.  Among participants in high disadvantage neighborhoods, disagreement with 
the items pertaining to pharmacists and SEP staff was associated with increased receptive syringe 
sharing.  This finding is consistent with our hypothesis that the fear of being mistreated at safe syringe 
sources may deter PWID from using them, increasing the likelihood of high-risk injection behavior.  
However, among participants in low disadvantage neighborhoods, the direction of the association was 
contrary to what we would expect.  Participants who disagreed with the items pertaining to pharmacists 
and SEP staff were less likely to report receptive syringe sharing.  One explanation for this finding is 
related to injection drug use stigma.  Because injection drug use may be less common in low 
disadvantage neighborhoods, it may also be more heavily stigmatized.  Consequently, PWID in low 
disadvantage neighborhoods may be more susceptible to social isolation as a result of their injection drug 
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use.  Injectors who feel that pharmacists and SEP staff do not care about their health and well-being may 
be socially isolated from their communities – not only from non-drug users, but from other PWID as well.  
For this reason, they may be less likely to interact with other PWID, decreasing their risk of receptive 
syringe sharing. 
 The findings from our study should be considered in light of a number of limitations.  First, the 
data used in these analyses are cross-sectional, which prevents us from establishing the temporality of 
relations between social discomfort and high-risk injection behavior.  Longitudinal analyses are required 
to better understand the effects of social discomfort.  Second, outcome data on high-risk injection 
behavior were self-reported by participants.  Although this approach to data collection raises the 
possibility of bias, previous studies have shown that self-reported measures of injection risk behavior are 
accurate and reliable.157  Third, we cannot be certain of the validity of our measures of social discomfort.  
Research on the influence of this construct has been primarily qualitative in nature, and as far as we are 
aware, no psychometrically tested scales have been developed to measure it.  Although we used items 
that appear to pertain to social discomfort in the current analyses, it is possible that these items are 
correlated with a different construct altogether.  Despite this lack of certainty, however, we remain 
confident that our items captured the intended construct.  Factor analyses revealed that social discomfort 
items were related to one another, and relative levels of discomfort roughly approximated patterns 
observed in the qualitative literature (i.e. participants expressed the most positive attitudes toward SEP 
staff).  While further studies are needed to develop more comprehensive and reliable scales measuring 
social discomfort, this gap in the research should not delay efforts to investigate a potential barrier to 
sterile syringe access.  Fourth, the findings from our study may have limited external validity.  As 
described above, the participants in our sample were recruited from pharmacies, and may not reflect 
patterns of social discomfort and high-risk injection behavior present in the general population of PWID.   
Pharmacies that participated in PHARM-Link may have been staffed by employees who were especially 
supportive of offering extended services to PWID, which may have lowered levels of social discomfort in 
our sample.  Coupled with the lower injection risk profile of pharmacy-recruited PWID, this represents 
another pathway through which our findings may have been biased toward the null.  Finally, our study 
was conducted in New York City, where syringe availability is high and HIV prevention services are 
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extensive in comparison to other parts of the US.  Taken together, these circumstances indicate that the 
findings from our analyses are not broadly generalizable.  However, the sale of non-prescription syringes 
has been legalized in several states, creating new populations of pharmacy-using PWID across the 
country.  Understanding barriers to syringe access and patterns of risk behavior in this group will continue 
to be important.  Furthermore, as harm reduction approaches to addressing injection drug use become 
more commonplace, populations of PWID in urban areas will more closely resemble those in New York 
City. 
 To our knowledge, this is the first quantitative analysis to investigate the relation between social 
discomfort surrounding the acquisition of sterile syringes and high-risk injection behavior.  The influence 
of injection drug use stigma on risk behavior among PWID has been understudied in the literature, and 
our analyses offer important insights regarding one of the mechanisms through which it may operate.  In 
addition, our data afforded us the opportunity to explore how the effects of social discomfort, a 
psychosocial construct, may be modified by neighborhood context – another area in which research has 
been sorely lacking.  Although we did not detect associations between measures of social discomfort and 
high-risk injection behavior, our findings suggest the need for additional research on a variety of topics.  
Scales measuring injection drug use stigma and social discomfort should be developed to facilitate the 
investigation of these phenomena.  Alternative mechanisms linking injection drug use stigma and high-
risk injection behavior should be identified to improve our understanding of how this construct shapes 
outcomes.  Studies focusing on PWID who do not use safe syringe sources should be conducted to 
identify barriers to syringe access in this group.  Finally, given the importance of neighborhood in 
determining risk behavior among PWID, future studies should continue to explore the interplay of 
psychosocial and neighborhood constructs.  Despite the availability of syringes from both SEPs and 
pharmacies, PWID continue to face challenges accessing sterile injection equipment from safe, legal 
sources.  Identifying factors in the risk environment that increase the likelihood of high-risk injection 







CHAPTER 4 TABLES AND FIGURES 
Table 4.1  Descriptive characteristics of PHARM-Link study participants by level of social discomfort (N=484) 
 






    No. (%) or Mean (SD)  
Age 
 
43.5 (9.3) 43.2 (9.7) 43.8 (8.9) 0.47 
Male 354 (73.1%) 176 (74.0%) 178 (72.4%) 0.69 
Race/ethnicity       0.89 
 
Hispanic/Latino (regardless of race) 251 (51.9%) 121 (50.8%) 130 (52.9%) 
 
 
Non-Hispanic Black 129 (26.7%) 64 (26.9%) 65 (26.4%) 
 
 
Non-Hispanic White and other 104 (21.5%) 53 (22.3%) 51 (20.7%) 
 Less than high school diploma/GED 179 (37.0%) 93 (39.1%) 86 (35.0%) 0.35 
Income in the past year 8951 (10412) 8908 (11247) 8994 (9558) 0.93 
Homeless in the past 6 months 162 (33.5%) 87 (36.6%) 75 (30.5%) 0.16 
Gay, lesbian, or bisexual 52 (10.7%) 33 (13.9%) 19 (7.7%) 0.03c 
Injected daily in the past 3 months 167 (34.5%) 87 (36.6%) 80 (32.5%) 0.35 
HIV positive 63 (13.0%) 29 (12.3%) 34 (13.9%) 0.61 
Drug treatment in the past 3 months 367 (75.8%) 175 (74.2%) 192 (78.7%) 0.24 
Ever harassed by police at SEPs or pharmacies 161 (33.3%) 86 (36.1%) 75 (30.5%) 0.19 
PHARM-Link intervention group 225 (46.5%) 113 (47.5%) 112 (45.5%) 0.67 
  
      
 High-risk injection behaviors (in the past 3 months)       
 
 
Receptive syringe sharing 109 (22.5%) 61 (25.5%) 48 (20.0%) 0.11 
 
Unsterile syringe use 238 (49.2%) 127 (53.4%) 111 (45.1%) 0.07 
 
Use of unsafe syringe source 133 (27.5%) 62 (26.1%) 71 (28.9%) 0.49 
  
      
 Neighborhood-level characteristics       





a Low and high social discomfort groups were created by dichotomizing the social discomfort score at the median.  Low social discomfort = 
social discomfort score < 4, High social discomfort = social discomfort score ≥ 4. 
b p-value for comparison of low and high social discomfort groups.  p-values are from t-tests for continuous variables and Chi-square tests 
for categorical variables. 









Table 4.2  Social discomfort items measured among PHARM-Link study participants (N=484) 
 Social discomfort item Mean (SD) 
I feel comfortable trying to buy a syringe at any pharmacy even if I don't know if they'll sell to me. 1.25 (0.86) 
It doesn't matter to me if people know why I'm buying syringes when I'm in line at the pharmacy. 1.20 (0.98) 
It wouldn't matter if people saw me walk into a syringe exchange program. 1.17 (0.89) 
Pharmacists care about my health and well-being. 1.19 (0.81) 
The staff at syringe exchange programs seems to care about my health and well-being. 0.85 (0.70) 
Social discomfort scoreb 3.62 (2.06) 
a PHARM-Link participants were asked to indicate their level of agreement with each social discomfort item on a 4-point Likert scale: 
Strongly agree=0, Agree=1, Disagree=2, Strongly disagree=3. 
b The social discomfort score was calculated as a simple sum of participants' responses to the first three items listed in this table.  This 








Table 4.3  Unadjusted and adjusted associations between social discomfort items and high-risk injection behavior among PHARM-Link study participants (N=484) 
 
  Receptive syringe sharing Unsterile syringe use Use of unsafe syringe source 
  












I feel comfortable trying to buy a syringe at any 
pharmacy even if I don't know if they'll sell to 
me. 
0.92 (0.76, 1.12) 0.97 (0.80, 1.18) 0.92 (0.82, 1.02) 0.93 (0.83, 1.04) 1.02 (0.86, 1.20) 1.07 (0.91, 1.26) 
It doesn't matter to me if people know why I'm 
buying syringes when I'm in line at the 
pharmacy. 
0.90 (0.75, 1.07) 0.92 (0.78, 1.09) 0.95 (0.86, 1.04) 0.96 (0.88, 1.05) 1.04 (0.90, 1.20) 1.06 (0.93, 1.22) 
It wouldn't matter if people saw me walk into a 
syringe exchange program. 
0.94 (0.78, 1.13) 0.96 (0.80, 1.15) 0.94 (0.85, 1.05) 0.96 (0.86, 1.07) 1.01 (0.86, 1.18) 0.99 (0.84, 1.16) 
Pharmacists care about my health and well-
being. 
0.96 (0.78, 1.17) 0.96 (0.78, 1.19) 1.02 (0.91, 1.14) 1.02 (0.92, 1.15) 1.13 (0.95, 1.33) 1.11 (0.94, 1.31) 
The staff at syringe exchange programs seems 
to care about my health and well-being. 
0.97 (0.76, 1.24) 0.97 (0.77, 1.22) 1.08 (0.95, 1.22) 1.08 (0.95, 1.22) 1.28 (1.06, 1.54)a 1.27 (1.05, 1.52)a 
Social discomfort score 0.95 (0.88, 1.03) 0.97 (0.90, 1.05) 0.96 (0.92, 1.01) 0.97 (0.93, 1.01) 1.01 (0.95, 1.08) 1.02 (0.96, 1.09) 
a p < 0.05 
Note: Values shown are risk ratios and 95% confidence intervals for 1-unit increases in social discomfort items and social discomfort score.  Adjusted models were controlled 
















Figure 4.1.  Effect modification of associations between social discomfort items and receptive syringe sharing by 
neighborhood disadvantage.  Predicted probabilities of receptive syringe sharing were estimated when the 
neighborhood deprivation index was fixed at the 25th percentile (low neighborhood disadvantage) and the 75th 
percentile (high neighborhood disadvantage).  Models were adjusted for the following individual-level confounders: 
age, gender, race, education, income, homelessness, sexual orientation, injection frequency, and experience of 
police harassment at SEPs or pharmacies.  Interaction p-values are from significance tests of cross-product terms 
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 Evidence gathered over the past thirty years suggests that interventions designed to motivate 
individual behavior change will be insufficient to eliminate the transmission of BBVs among PWID.98,99  
More recent studies have found that high-risk injection behavior is shaped not only by individual-level 
characteristics, but also by the environments in which these behaviors occur.41-49  In an effort to deepen 
our understanding of how contextual factors influence high-risk injection behavior, this dissertation 
examined two understudied elements of the risk environment – neighborhood context and the social 
discomfort experienced by PWID when acquiring syringes at SEPs and pharmacies. 
 A systematic review of the literature regarding the influence of neighborhood context on injection 
drug use behavior was conducted to summarize and synthesize current knowledge on this relation.  The 
findings revealed that few neighborhood-level characteristics have been evaluated as potential 
determinants of injection drug use behavior.  Research has primarily focused on structural aspects of the 
neighborhood environment, such as neighborhood socioeconomic disadvantage and spatial access to 
pharmacies and SEPs, while social characteristics have yet to be investigated.  Mediators and modifiers 
of relations between neighborhood-level factors and injection drug use behavior have also received little 
attention.  Although current evidence suggests that spatial proximity to SEPs is associated with increased 
SEP use and decreased injection risk behavior, too few studies have been conducted on other elements 
of the neighborhood environment to draw definitive conclusions. 
 This dissertation sought to address these research gaps through a number of quantitative 
analyses.  First, the association between neighborhood socioeconomic disadvantage and high-risk 
injection behavior was examined among PWID in New York City.  Analyses showed that neighborhood 
disadvantage was associated with safer injection behaviors.  PWID in disadvantaged neighborhoods 
were less likely to report receptive syringe sharing and unsterile syringe use than their counterparts in 
neighborhoods that were relatively better off.  Associations between neighborhood disadvantage and 
decreased unsterile syringe use were attenuated by drug-related police activity, while associations 
between neighborhood disadvantage and the use of unsafe syringe sources were modified by SEP 
accessibility.  In neighborhoods with high SEP accessibility, neighborhood disadvantage was associated 
with decreased use of unsafe syringe sources, while in neighborhoods with low SEP accessibility, 
neighborhood disadvantage was associated with increased use of unsafe syringe sources. 
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 To learn more about how elements of the social environment influence risk behavior among 
PWID, additional analyses were performed to study the relation between social discomfort and high-risk 
injection behavior.  In main effect models, measures of social discomfort were not associated with high-
risk injection behavior, with the exception of the item pertaining to SEP staff (“The staff at syringe 
exchange programs seems to care about my health and well-being”).  PWID who disagreed with this item 
were more likely to report the use of an unsafe syringe source.  In addition, neighborhood socioeconomic 
disadvantage was investigated as a potential modifier of relations between social discomfort and high-risk 
injection behavior.  Effect modification was observed between the items pertaining to SEP staff and 
pharmacists (“Pharmacists care about my health and well-being”) and neighborhood socioeconomic 
disadvantage in models of receptive syringe sharing.  In disadvantaged neighborhoods, disagreement 
with these items was associated with increased receptive syringe sharing, while in less disadvantaged 
neighborhoods, disagreement was associated with decreased receptive syringe sharing. 
 Together, the findings from this dissertation constitute an important contribution to our 
understanding of the influence of the risk environment on injection behavior among PWID.  As far as I am 
aware, the systematic literature review included here is the first to catalogue existing studies of the 
relation between neighborhood context and injection drug use behavior.  Not only does this review 
identify elements of the neighborhood environment that appear to shape behavior among injectors, but it 
also describes the limitations of this literature.  As a result, it may serve to guide future research on the 
influence of neighborhood on PWID. 
Analyses on the association between neighborhood socioeconomic disadvantage and high-risk 
injection behavior enhance our understanding of how local-area poverty may shape syringe sharing and 
syringe acquisition.  Although similar studies have been conducted among PWID in the United States and 
Canada,42,43 this dissertation likely contains the first analysis to examine the association between 
neighborhood disadvantage and high-risk injection behavior among PWID in New York City.  As New 
York City contains the largest population of PWID in the United States,14 understanding how 
neighborhood-level factors shape individual-level behavior in this setting is of particular importance.  The 
results of these analyses also open new avenues of inquiry for research on the influence of neighborhood 
disadvantage on PWID.  As mentioned above, neighborhood disadvantage was found to be associated 
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with safer injection behaviors.  Given the tendency of many investigators to equate neighborhood 
disadvantage with riskier injection behaviors,50,155 the results presented in this dissertation encourage the 
exploration of alternative pathways linking neighborhood poverty to injection risk behavior.  In addition, 
the identification of interactions among neighborhood disadvantage, SEP accessibility, and drug-related 
police activity addresses an important gap in the literature on neighborhood and injection drug use – the 
dearth of studies examining modifiers of neighborhood effects.  The finding that relations between 
neighborhood disadvantage and high-risk injection behavior were dependent on levels of SEP 
accessibility and drug-related police activity reinforces the importance not only of studying contextual 
factors, but also of their interplay in shaping risk behavior among PWID. 
 Finally, analyses on the association between social discomfort and high-risk injection behavior 
constitute the first quantitative investigation of this relation.  Although no associations were detected in 
main effect models, this study represents an important first step toward understanding social factors that 
influence syringe access.  To date, most research on the distribution of sterile syringes from SEPs and 
pharmacies has focused on whether these interventions are effective in decreasing syringe sharing and 
BBV transmission among PWID.  This dissertation extends the literature by moving past the question of 
whether SEPs and pharmacy syringe sales are effective, to studying what can be done to improve their 
effectiveness.  The investigation of interactions between social discomfort and neighborhood 
socioeconomic disadvantage also advances the literature by evaluating interactions between elements of 
the structural and social environments.  Few, if any, analyses have tested similar interactions in studies of 
injection drug use behavior. 
 Although the research presented here advances our knowledge of how contextual factors may 
influence behaviors surrounding drug injection, these analyses are not without limitations.  Cross-
sectional data were used to measure associations among neighborhood socioeconomic disadvantage, 
social discomfort, and high-risk injection behavior, precluding the establishment of causality.  This is a 
common limitation of neighborhoods research, given the high financial and temporal burdens associated 
with the collection of longitudinal data.  Additionally, the PHARM-Link sample was comprised of 
pharmacy-recruited PWID, whose characteristics may differ from those of injectors in the general 
population.  As discussed above, PWID who access syringes from pharmacies may have lower levels of 
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both social discomfort and high-risk injection behavior.  Together, these characteristics may have biased 
associations between social discomfort and high-risk injection behavior toward the null.  Although this 
limitation curtails our ability to draw conclusions with regard to the influence of social discomfort, non-
prescription syringe laws have been passed in several states, and the targeted study of PWID who utilize 
pharmacy services will continue to be important.  Finally, the use of a New York City sample of PWID may 
limit the external validity of the findings.  Because syringe access and HIV prevention services are 
generally more extensive in New York City than in other parts of the United States, relations observed 
among neighborhood disadvantage, social discomfort, and high-risk injection behavior in this dissertation 
may not reflect those in other cities or in rural areas.  However, as harm reduction interventions 
implemented in New York City are applied elsewhere, the similarity between our study sample and the 
general population of PWID in the United States will grow. 
 Another important limitation that was not discussed in the chapters above was the inability to 
study injection drug use stigma directly.  The PHARM-Link survey did not include a measure of injection 
drug use stigma, which precluded the investigation of how stigma was related to neighborhood 
socioeconomic disadvantage and social discomfort.  Qualitative evidence suggests that social discomfort 
is a product of injection drug use stigma; however, the role that stigma may play in relations between 
neighborhood disadvantage and high-risk injection behavior is less clear.  Multiple conceptual frameworks 
have posited that stigma arises from differences in social, economic, and political power between 
groups.161,162  Given that PWID are generally a poor, socially marginalized population, this would suggest 
that injection drug use stigma mediates associations between neighborhood disadvantage and high-risk 
injection behavior.  PWID in disadvantaged neighborhoods may share more characteristics in common 
with other community members than their counterparts in less disadvantaged neighborhoods.  As a 
result, levels of injection drug use stigma may be lower in disadvantaged neighborhoods, potentially 
leading PWID in these areas to engage in fewer high-risk injection practices.  This model is consistent 
with our finding that neighborhood socioeconomic disadvantage was associated with decreased receptive 
syringe sharing and unsterile syringe use.  However, it is also possible that injection drug use stigma 
modifies associations between neighborhood disadvantage and high-risk injection behavior.  Analyses of 
the relation between social discomfort and high-risk injection behavior in this dissertation revealed 
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statistically significant interactions between specific measures of social discomfort and neighborhood 
disadvantage.  If social discomfort is caused by injection drug use stigma, it is possible that similar 
interactions exist between neighborhood disadvantage and injection drug use stigma as well.  
Understanding the role of stigma in the production of high-risk injection behavior may be vitally important 
to the reduction of unsafe injection practices among PWID. 
Despite the limitations of the analyses presented above, this dissertation highlights numerous 
directions for future research.  The influence of neighborhood disadvantage on other high-risk injection 
behaviors should be investigated to find out whether local-area poverty influences these outcomes as 
well.  Potential links between neighborhood disadvantage and the sharing of other injection equipment 
(e.g. cotton, cookers, water) are of particular interest, given their high prevalence among PWID and their 
role in facilitating BBV transmission.7  Scales measuring injection drug use stigma and social discomfort 
should be developed to facilitate the study of these phenomena.  Relations among injection drug use 
stigma, neighborhood socioeconomic disadvantage, and social discomfort should be investigated to 
enhance our understanding of how stigma influences high-risk injection behavior.  Potential barriers to the 
use of SEPs and pharmacies should be studied among samples of PWID that include injectors who do 
not use safe syringe sources, or who do so infrequently.  Finally, future research should investigate the 
potential salutary effects of disadvantaged neighborhoods. 
Overall, our findings provide strong support for the importance of the risk environment in 
determining behavior among PWID.  Not only were elements of the structural and social environments 
found to influence high-risk injection behavior, but specific elements of these environments were found to 
interact with one another to shape outcomes.  Although great strides have been made toward curbing 
BBV transmission through the implementation of SEPs and pharmacy syringe sales, the results of this 
dissertation show that other aspects of the risk environment must be addressed if injection risk behavior 
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APPENDIX A: Description of the search strategy used for the systematic literature review 
 
The PubMed, Web of Science, and PsycINFO databases were systematically searched for journal articles 
pertaining to the topic of this review.  All database searches were performed on December 12, 2014.  The 
strategies used to search each database are described in detail below. 
 
A. PubMed search 
The PubMed search was performed in two steps.  In the first step, only MeSH terms were used to identify 
pertinent articles, while in the second step, a keyword search was performed to find articles not identified 
by the MeSH term search. 
 
Step 1. The following equations of MeSH terms were entered into the PubMed search window.  Results 
were limited to English language articles published between January 1, 1995 and December 14, 2014.  
Results were further restricted to those listing “Journal Article” as the document type. 
 
Equations of MeSH terms:  
A.1 – Combination of MeSH terms related to neighborhood and spatial context 
"Residence Characteristics"[Mesh] OR "Spatial Analysis"[Mesh] OR "Small-Area Analysis"[Mesh] OR 
"Environment"[Mesh : NoExp] OR "Environment Design"[Mesh] OR "Social Environment"[Mesh]  
 
A.2 – Combination of MeSH terms related to injection drug use behavior 
"Substance Abuse, Intravenous"[Mesh] 
 
In the “History” field of PubMed, equations A.1 and A.2 were combined with the AND operator, yielding 
475 results.  
 
Step 2. The following equations of keywords and phrases were entered into the PubMed search window.  
The [Title/Abstract] option was added to each keyword or phrase to restrict the results to those articles 
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including these words in their titles and/or abstracts.  As above, results were limited to English language 
articles published between 1995/01/01 and 2014/12/12 and listing “Journal Article” as the document type. 
 
Equations of keywords:  
A.3 – Combination of keywords related to neighborhood and spatial context 
Community[Title/Abstract] OR Neighborhood[Title/Abstract] OR Neighbourhood[Title/Abstract] OR 
Spatial[Title/Abstract] OR Area[Title/Abstract] OR Environment*[Title/Abstract] OR 
Place[Title/Abstract] OR Geographic[Title/Abstract] OR Context*[Title/Abstract] 
 
A.4 – Combination of keywords related to injection drug use behavior 
(Intravenous drug[Title/Abstract]) OR (Injecting drug[Title/Abstract]) OR (Injection drug[Title/Abstract]) 
OR (Inject drugs[Title/Abstract]) OR (Injectors[Title/Abstract]) 
 
In the “History” field, equations A.3 and A.4 were combined using the AND operator, yielding 2658 
results.   
Subsequently, the results from the MeSH term and keyword searches were combined in EndNote X7, 
and duplicates were removed.  A total of 2971 articles were identified by the PubMed search for potential 
inclusion in the review. 
 
 
B. Web of Science search 
Because Web of Science does not use controlled vocabulary, only a keyword search was performed in 
this database to identify candidate articles.  The Advanced Search tool was used to search the Web of 
Science Core Collection.  Results were limited to English language publications from January 1, 1995 on.  
Results were further restricted to those listing “Article” as the document type.  The following equations 
were entered into the Web of Science search window, where “TS” is indicative of a “Topic” search.     
 
Equations of keywords: 
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B.1 – Combination of keywords related to neighborhood and spatial context 
TS=(Community OR Neighborhood OR Neighbourhood OR Spatial OR Area OR Environment* OR 
Place OR Geographic OR Context*) 
 
B.2 – Combination of keywords related to injection drug use behavior 
TS=(Intravenous drug OR Injection drug OR Injecting drug OR Inject drugs OR Injectors) 
 
In the “Search History” tab, equations B.1 and B.2 were combined using the AND operator.  Results were 
restricted to those falling within the following Research Categories: Substance abuse, Public 
environmental occupational health.  This search yielded 2422 articles for potential inclusion in the review. 
 
 
C. PsycINFO search 
The PsycINFO search was performed in two steps.  In the first step, only controlled vocabulary terms 
were used to identify pertinent articles, while in the second step, a keyword search was performed to find 
articles not identified by the controlled vocabulary search.    
 
Step 1. The following equations of controlled vocabulary terms were entered into the PsycINFO search 
window.  Results were limited to English language articles published between January 1, 1995 and 
“Current.”  Results were further restricted to those listing “Journal” as the publication type. 
 
Equations of controlled vocabulary terms: 
C.1 – Combination of controlled vocabulary terms related to neighborhood and spatial context: 
"Communities"[Explode] OR "Environment"[Do Not Explode] OR "Social Environments"[Explode] 
 
C.2 – Combination of controlled vocabulary terms related to injection drug use behavior: 




In the “Search History” field of PsycINFO, equations C.1 and C.2 were combined with the AND operator, 
yielding 130 results. 
 
Step 2. The following equations of keywords and phrases were entered into the PsycINFO search 
window.  As above, results were limited to English language articles published from January 1, 1995 on 
and listing “Journal” as the publication type. 
 
Equations of keywords:  
C.3 – Combination of keywords related to neighborhood and spatial context 
Community OR Neighborhood OR Neighbourhood OR Spatial OR Area OR Environment* OR Place 
OR Geographic OR Context*  
 
C.4 – Combination of keywords related to injection drug use behavior 
Intravenous drug OR Injecting drug OR Injection drug OR Inject drugs OR Injectors 
 
In the “Search History” field, equations C.3 and C.4 were combined using the AND operator, yielding 
1310 results. 
Subsequently, the results from the controlled vocabulary and keyword searches were combined in 
EndNote X7, and duplicates were removed.  A total of 1311 articles were identified by the PsycINFO 
search for potential inclusion in the review. 
 
 
The final group of articles screened for the review was constructed by combining the results from the 
PubMed, Web of Science, and PsycINFO searches.  After the removal of duplicates in EndNote X7, a 
total of 4578 articles were identified for potential inclusion in the review.  This list was subsequently 
narrowed to 22 articles after screening by title, abstract, and full-text.  
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APPENDIX B: Detailed quantitative methods 
Parent study overview: The PHARM-Link study 
This dissertation utilized data collected from PWID enrolled in the Pharmacists as Resources 
Making Links to Community Services (PHARM-Link) study.  The PHARM-Link study was a pharmacy-
randomized intervention trial designed to evaluate the impact of pharmacy-delivered health and social 
service referrals on a variety of outcomes among pharmacy staff and PWID.  Previous studies have 
shown that, in addition to distributing sterile syringes, SEPs are instrumental in linking PWID to health and 
social services, such as HIV testing and drug treatment.  The purpose of PHARM-Link was to evaluate 
the extension of this public health role to pharmacies.  Outcomes of interest among pharmacy staff 
included attitudes toward sterile syringe sales and enhanced pharmacy services for drug users.  Among 
PWID, changes in access to HIV testing, primary care services, drug treatment, and health insurance 
were evaluated. 
 
Eligibility, recruitment, and data collection 
ESAP-registered pharmacies in high drug activity neighborhoods in New York City were invited to 
participate in the study.  Pharmacies were eligible to participate if they met the following criteria: 1) at 
least one nonprescription syringe-purchasing customer per month, 2) at least one new nonprescription 
syringe-purchasing customer per month who became a regular customer, 3) no requirements of 
additional documentation from customers during syringe transactions, and 4) a willingness to sell syringes 
to PWID.  A total of 172 pharmacies were deemed eligible for the study, of which 130 agreed to 
participate.  Pharmacy staff were interviewed at baseline, 6-month follow-up, and 12-month follow-up.  
Once baseline interviews were completed, participating pharmacies were randomized to intervention, 
primary control, and secondary control arms.  Twenty-four pharmacies dropped out of the study before 
randomization, and the remaining 106 pharmacies were randomized to study arms in roughly equal 
numbers.  Intervention pharmacies offered PWID referrals to health and social services via print materials 
and a drug user-specific web resource guide.  Primary and secondary control pharmacies only offered 




 PWID were recruited into PHARM-Link by pharmacy staff working in intervention and primary 
control pharmacies.  The purpose of the secondary control arm was to evaluate intervention effects 
among pharmacy staff only, and therefore, was not involved in recruitment of PWID.  Recruitment took 
place when PWID visited intervention and primary control pharmacies to purchase nonprescription 
syringes.  During nonprescription syringe transactions with PWID, pharmacy staff were trained to 
discreetly describe the PHARM-Link study and to offer a study appointment with research staff within one 
week of the pharmacy visit.  At the study appointment, research staff met with participants at the 
pharmacy and accompanied them to a nearby restaurant, park, or library for the purposes of data 
collection.  After confirming participants were at least 18 years of age using photo identification, research 
staff obtained informed consent and invited participants to complete a 45-minute Audio Computer 
Assisted Self Interview (ACASI) on study laptops.  The survey ascertained data on a variety of topics, 
including socio-demographic characteristics, drug use history, HIV risk behaviors, syringe access and 
disposal practices, and history of access to medical and social services.  Participants who reported 
injection of an illicit drug in the past six months were also invited to return for a 3-month follow-up ACASI 
survey.  Participants were compensated with $20 and a round-trip Metrocard for completion of the 
baseline survey and $25 for completion of the follow-up survey.  Baseline data collected between March 
2009 and October 2010 were combined and used to perform the analyses in this dissertation.  The 
PHARM-Link study was approved by the institutional review boards at the New York Academy of 
Medicine and Columbia University. 
 
Additional data source: 2006-2010 American Community Survey 5-year estimates 
The American Community Survey (ACS) is a nationwide, continuous survey administered by the 
US Census Bureau to collect data on the demographic, housing, social, and economic characteristics of 
the US population.  Each year, a total of 3 million addresses are chosen from the Census Bureau’s 
Master Address File to participate, representing 2.5% of the US population.149  Each household is 
contacted and asked to complete the survey either online or on paper.150  For geographic areas with 
populations larger than 65,000, the data gathered in a single year are sufficient to generate area-level 
estimates of the characteristics included in the survey.  However, more data are required to produce 
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estimates for geographic areas with smaller populations.  The Census Bureau uses three years of data to 
calculate estimates for areas with populations as low as 20,000 and five years of data for all remaining 
units of census geography.  Census tracts normally have populations of less than 20,000; therefore, 
estimates for these units are generated based on data accumulated over five consecutive years.  These 
estimates are interpreted as the average value of a given characteristic over the time period during which 
the data were collected to produce the estimate.  Census tract-level demographic and socioeconomic 
data were abstracted from the 2006-2010 ACS 5-year estimates for use in this analysis. 
 
Individual-level measures 
High-risk injection behaviors 
The outcomes examined in this dissertation were the following high-risk injection behaviors 
reported by PWID on the PHARM-Link survey: unsterile syringe use, receptive syringe sharing, and the 
acquisition of syringes from unsafe sources.  Unsterile syringe use includes both receptive syringe 
sharing and injectors’ reuse of their own syringes.  This behavior was measured using the following item: 
“In the past three months, how often did you use a syringe that you were absolutely sure had not been 
used by anyone, not even yourself?  By this, I mean you heard or could feel the cap “snap” when you 
turned the cap to remove it from the needle?”  Participants were asked to respond to this item on a 6-
point Likert scale ranging from “Never” to “Always.”  Responses were dichotomized so that participants 
who endorsed any option other than “Always” were considered to have engaged in unsterile syringe use.  
Similarly, receptive syringe sharing was measured using the following item: “In the past three months, 
how often did you use a syringe that you knew someone had used before you?”  Participants were asked 
to respond to this item on a 6-point Likert scale ranging from “Never” to “Always.”  Responses were 
dichotomized so that participants who endorsed any option other than “Never” were considered to have 
engaged in receptive syringe sharing.  Finally, to assess the acquisition of syringes from unsafe sources, 
participants were asked to report the frequency with which they obtained syringes from friends, relatives, 
syringe dealers, and shooting galleries in the past three months, using a 7-point Likert scale ranging from 
“Never” to “Everyday.”  Responses were dichotomized so that participants who reported obtaining 




Social discomfort surrounding the acquisition of sterile syringes 
Social discomfort surrounding the acquisition of sterile syringes from pharmacies and SEPs was 
measured among PWID using five items from the PHARM-Link survey.  Participants were asked to 
indicate their level of agreement with the following items on a 4-point Likert scale ranging from “Strongly 
agree” to “Strongly disagree”: 1) It doesn’t matter to me if people know why I’m buying syringes when I’m 
in line at the pharmacy, 2) I feel comfortable trying to buy a syringe at any pharmacy even if I don’t know 
if they’ll sell to me before I go in the store, 3) It wouldn’t matter to me if people saw me walk into a syringe 
exchange program, 4) Pharmacists care about my health and well-being, and 5) The staff at syringe 
exchange programs seems to care about my health and well-being.  The response format for each of 
these items was recoded to a numeric scale ranging from 0 to 3, where higher scores were indicative of 
greater disagreement with the items, and therefore, greater social discomfort.  These items were entered 
into analyses individually as continuous variables.   
 In addition to examining each item individually, the scores from the first three items listed above 
were combined in a simple sum to create a social discomfort score (range: 0-9).  Although exploratory 
factor analyses revealed that all five items loaded onto a single factor, the items pertaining to pharmacists 
and SEP staff may reflect a different dimension of social discomfort, and for this reason, were not 
included in the sum score.  Exploratory factor analyses limited to the first three items showed that they 
loaded strongly on a single factor, with loadings >0.60 for each item.  The social discomfort score was 
entered into analyses as a continuous variable (α=0.62).  Factor analyses were performed in Mplus 6.1. 
 
Individual-level covariates 
On the basis of previous research regarding injection risk behavior among PWID, several 
individual-level covariates were evaluated as potential confounders of associations of interest.  These 
data were collected through the PHARM-Link survey and included the following variables: age 
(continuous), gender (male/female), race (black/Latino/white, other), education (high school graduate, 
GED/less than high school), income (continuous), PHARM-Link randomization group (intervention/primary 
control), homelessness in the past 6 months (yes/no), sexual orientation (gay, lesbian, 
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bisexual/heterosexual), HIV status (positive/negative or unknown), injection frequency (daily/less than 
daily), drug treatment in the past 3 months (yes/no), ever harassed by police at SEPs or pharmacies 
(yes/no), and SEP use in the past 3 months (yes/no).   
Income was measured using two items: 1) “What was your total legal income (on the books) 
before taxes in the past year, this includes public assistance, SSI, etc.?” and 2) “What was your total 
untaxable income (off the books) in the past year?”  Because these items had categorical response 
options, the midpoint of categories selected by participants were summed to generate a continuous 
estimate of total income in the past year.  This approach has been used in other studies to derive 
continuous measures of education and income from categorical data.148 
 
Neighborhood-level measures 
Neighborhood socioeconomic disadvantage 
 Indicators of neighborhood socioeconomic disadvantage were created using census tract-level 
data from the 2006-2010 American Community Survey 5-year estimates.  Census tract-level ACS data 
were linked to participants in our sample using data collected on the PHARM-Link survey.  Participants 
were asked to specify “the city and neighborhood you live in” and “the cross streets where you spend 
most of your time.”  Street intersections falling within New York City boundaries were geocoded in ArcGIS 
10.1, and circular buffers with radii of 0.5 km were drawn around each intersection to approximate 
participants’ neighborhoods.  A 0.5 km-buffer, corresponding to a 10-minute walking distance, has 
generally been accepted as a reasonable approximation of the size of the local area to which the average 
neighborhood resident is exposed.43,44,152  Because the area within these buffers included parts of 
multiple census tracts, census-tract level data from the ACS were used in conjunction with the area of the 
census tract parts within each buffer to calculate an area-weighted mean for each socioeconomic 
indicator.  These area-weighted means were used as measures of neighborhood disadvantage for each 
individual in the analysis.  Although many studies on the relation between contextual factors and 
individual-level outcomes use census tracts as proxies for neighborhood, circular buffers centered on 
specific locations given by study participants may be a more meaningful way to represent local 
environments than administrative units whose boundaries are artificial.115 
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 The following neighborhood-level factors were considered as exposures of interest: percent of 
residents living in poverty, percent receiving public assistance, percent with low education (defined as the 
percent of residents >25 years of age without a high school diploma or GED), percent >16 years of age 
unemployed, percent residential instability (defined as the percent of residents living in a different house 
than 1 year ago), and an index of neighborhood deprivation.  The neighborhood deprivation index was 
calculated using four census tract-level characteristics abstracted from the 2006-2010 ACS: percent of 
residents living in poverty, percent receiving public assistance, percent >16 years of age unemployed, 
and percent of households that are female-headed.  These variables were standardized to the study 
sample using Z-scores and summed to calculate an index score.  Positive values indicate areas with high 
neighborhood deprivation relative to the sample, while negative values indicate relative affluence.  A 
score of 0 represents neighborhoods with overall values equal to the sample mean.  Indices similar to this 
one have been used in a variety of studies to measure neighborhood socioeconomic disadvantage.153,154 
 
Syringe exchange program accessibility 
 As a measure of SEP accessibility, distances were calculated from street intersections reported 
by PHARM-Link participants to the nearest authorized SEP site.  A list of authorized SEP sites operating 
in New York City in February 2010 was obtained from the New York State Department of Health.  A total 
of 40 SEP sites were geocoded in ArcGIS 10.1, and distances from street intersections to the nearest 
SEP site were calculated along the street network.  Distances were measured in meters and log-
transformed for inclusion in statistical analyses. 
 
Drug-related police activity 
 As a measure of the intensity of drug-related police activity, the number of drug-related arrests 
per 1000 adult residents was calculated within community districts (named neighborhood units within New 
York City).  Data on the number of drug-related arrests occurring among adults in New York City police 
precincts in 2010 were obtained from the New York State Division of Criminal Justice Services.  Arrests 
were included if the most serious charge was a misdemeanor or felony offense for the possession, sale, 
or use of illicit drugs, drug paraphernalia, or a controlled substance.  Census tract-level data from the 
 
 115 
2010 US Decennial Census were used to calculate the adult population aged ≥ 16 in each police precinct.  
Census tract-level population data were aggregated to the precinct level according to the proportion of 
each census tract’s surface area that lay within each police precinct.  Precinct-level arrest rates per 1000 
adult residents were calculated by dividing the number of drug-related arrests within each precinct by the 
precinct population and multiplying by 1000.  Area-weighted means were used to aggregate precinct-level 
arrest rates to the community district level. 
 
Analytic sample 
A total of 592 participants completed the baseline PHARM-Link survey.  Of these, 61 reported 
insufficient data for geocoding (10.3%), 34 were missing data on a social discomfort item (5.7%), 20 were 
missing data on one or more individual-level covariates (3.4%), and 1 was missing data on a high-risk 
injection behavior (0.2%).  The final analytic sample contained 484 participants, or 81.7% of the original 
sample.  Participants excluded for missing data were similar to the analytic sample on all variables with 
three exceptions.  Excluded participants were younger than those included in the analysis, more likely to 
report their sexual orientation as gay, lesbian, or bisexual, and less likely to report police harassment at 
SEPs or pharmacies. 
 
Statistical analysis 
Because the PHARM-Link sample was pharmacy-recruited, and our research questions 
concerned the influence of neighborhood-level factors on individual-level behaviors, there were at least 
two ways in which our sample could be considered nested: 1) by pharmacy and 2) by neighborhood.  
Psuedo-intraclass correlation coefficients (ICCs) were used to determine the proportion of variation in the 
outcomes that was explained at the pharmacy and neighborhood levels.  For these analyses, community 
districts were used as proxies for neighborhood. 
In Chapters 3 and 4, measures of neighborhood socioeconomic disadvantage and social 
discomfort were evaluated as potential predictors of high-risk injection behavior.  These analyses were 
conducted using Poisson regression with robust error variance to account for the high prevalence of 
outcomes in the analytic sample (23%-49%).  The use of Poisson regression allowed the measurement of 
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associations using risk ratios as opposed to odds ratios, which do not approximate risk ratios in the 
setting of common outcomes.  Bivariable associations were estimated between all individual- and 
neighborhood-level covariates and high-risk injection behavior.  All multivariable analyses were adjusted 
for age, gender, race, education, and income.  Additional individual-level covariates that were associated 
with any high-risk injection behavior at the p<0.10 level in bivariable analyses were also included in 
adjusted models.  In analyses of the association between neighborhood socioeconomic disadvantage and 
high-risk injection behavior, the following individual-level covariates were tested: PHARM-Link 
randomization group, homelessness in the past 6 months, sexual orientation, HIV status, and injection 
frequency.  In analyses of the association between social discomfort and high-risk injection behavior, the 
same group of individual-level covariates was tested, in addition to drug treatment in the past 3 months, 
ever harassed by police at SEPs or pharmacies, and SEP use in the past 3 months.  Final models 
measuring associations between neighborhood socioeconomic disadvantage and high-risk injection 
behavior were adjusted for age, gender, race, education, income, homelessness, sexual orientation, and 
injection frequency.  Final models of associations between social discomfort and high-risk injection 
behavior were adjusted for the same set of individual-level covariates, in addition to ever harassed by 
police at SEPs or pharmacies.  Measures of neighborhood socioeconomic disadvantage and social 
discomfort were entered into adjusted models of high-risk injection behavior individually and in continuous 
form. 
Additional variables were evaluated as potential effect modifiers of the associations examined in 
Chapters 3 and 4.  Log of distance to the nearest SEP and drug-related arrest rates were evaluated as 
potential modifiers of the relation between neighborhood socioeconomic disadvantage and high-risk 
injection behavior.  Similarly, neighborhood socioeconomic disadvantage was evaluated as a potential 
modifier of associations between social discomfort and high-risk injection behavior.  Effect modification 
was assessed by entering cross-product terms into adjusted models of high-risk injection behavior and 
testing these terms for statistical significance.  All potential modifiers were entered into analyses 
separately and in continuous form.   
Supplementary analyses were performed to determine whether log of distance to the nearest 
SEP and drug-related arrest rates mediated associations between neighborhood socioeconomic 
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disadvantage and high-risk injection behavior.  Detailed methods and results from these analyses are 
provided in Appendix C.   








Syringe exchange program (SEP) accessibility and drug-related police activity were investigated 
as potential mediators of associations between neighborhood socioeconomic disadvantage and high-risk 
injection behavior.  Because our sample size was insufficient to perform a formal mediation analysis, 
mediation was assessed through the following three-step process:   
First, associations were measured between indicators of neighborhood socioeconomic 
disadvantage and high-risk injection behavior.  The methods and results from these analyses are 
described in Chapter 3.   
Second, analyses were performed to determine whether indicators of neighborhood 
socioeconomic disadvantage were associated with SEP accessibility and drug-related police activity.  As 
explained in Chapter 3, SEP accessibility was measured using the distance between each participant’s 
street intersection and the nearest SEP site along the street network.  Distances were measured in 
meters and log-transformed for inclusion in analyses.  Drug-related police activity was measured using 
drug-related arrest rates per 1000 adults, aggregated to the community-district level.  Both distance to the 
nearest SEP and drug-related arrest rates were entered into analyses in continuous form.  To measure 
associations between neighborhood socioeconomic disadvantage and SEP accessibility, unadjusted 
generalized estimating equation models were created for log of distance to the nearest SEP.  Cluster 
robust standard errors were used to correct for autocorrelation within community district areas.  
Associations between indicators of neighborhood socioeconomic disadvantage and drug-related police 
activity were measured using Pearson correlations. 
Third, analyses were performed to determine whether SEP accessibility and drug-related police 
activity were associated with the dichotomous indicators of high-risk injection behavior used in the main 
analyses – receptive syringe sharing, unsterile syringe use, and the use of unsafe syringe sources.  
These associations were measured using Poisson regression with robust error variance.  All models were 
adjusted for the same set of individual-level covariates used in the main effect models in Chapter 3 – age, 
gender, race, education, income, homelessness, sexual orientation, and injection frequency. 
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 The existence of statistically significant associations linking neighborhood disadvantage to high-
risk injection behavior, neighborhood disadvantage to SEP accessibility (or drug-related police activity), 
and SEP accessibility (or drug-related police activity) to high-risk injection behavior was considered 
evidence of mediation. 
 
RESULTS 
 Table C.1 shows regression coefficients from unadjusted GEE models measuring associations 
between indicators of neighborhood socioeconomic disadvantage and SEP accessibility.  Increases in the 
percentage of neighborhood residents living in poverty, the percentage receiving public assistance, and 
the neighborhood deprivation index were all associated with smaller distances to the nearest SEP.  
Increases in the percentage unemployed was also marginally associated with closer SEP sites (p=0.06).  
Neither the percentage of residents with low education nor the percentage with residential instability were 
associated with SEP accessibility. 
 Table C.2 displays Pearson correlation coefficients for indicators of neighborhood socioeconomic 
disadvantage and drug-related police activity, both measured at the community district level.  Statistically 
significant, positive correlations were observed between all indicators of disadvantage and drug-related 
arrest rates, with the exception of the percentage of residents with residential instability.  Correlations 
between drug-related arrest rates and the following indicators were particularly strong (r>0.75): the 
percentage living in poverty, the percentage receiving public assistance, and the neighborhood 
deprivation index.  Figure C.1 depicts the relation between the neighborhood deprivation and drug-related 
arrest rates using a scatter plot. 
 Table C.3 presents both unadjusted and adjusted associations measuring the influence of SEP 
accessibility and drug-related police activity on high-risk injection behavior in the past three months.  
Neither log of the distance to the nearest SEP nor drug-related arrest rates were associated with 
indicators of high-risk injection behavior. 
 In summary, neighborhood socioeconomic disadvantage was associated with both increased 
SEP accessibility and increased drug-related police activity.  The direction of these associations is 
consistent with what we might hypothesize.  However, neither SEP accessibility nor drug-related police 
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activity were associated with high-risk injection behavior, suggesting that these variables did not mediate 
relations between neighborhood socioeconomic disadvantage and high-risk injection behavior in our 
sample.  As a result, we focus our main analyses on the role of SEP accessibility and drug-related police 





APPENDIX C TABLES AND FIGURES 
 
Table C.1  Unadjusted associations between indicators of neighborhood socioeconomic 
disadvantage and the log of distance to the nearest syringe exchange program among PHARM-Link 
study participants (N=484) 
Indicator of neighborhood socioeconomic 
disadvantage 
Proportional change in distance to the nearest 
syringe exchange program (95% CI) 
% poverty -33% (-49%, -13%)a 
% public assistance -64% (-82%, -26%)a 
% low education -14% (-32%, 11%) 
% unemployed -49% (-75%, 3%) 
% residential instability 14% (-26%, 75%) 
Neighborhood deprivation index -38% (-53%, 17%)a 
a p < 0.05 
Note: Values shown are proportional changes in distance to the nearest syringe exchange program 
and 95% confidence intervals calculated from linear regression models in which generalized 
estimating equations were used to account for autocorrelation within community district areas.  
Proportional changes reflect a 10% increase (e.g. 10% to 20%) for all indicators of neighborhood 
socioeconomic disadvantage, with the exception of neighborhood deprivation index.  For 







Table C.2  Pearson correlations between indicators of neighborhood socioeconomic disadvantage 
and drug-related arrests per 1000 adults in New York City community districts in 2010 (N=68) 
 
Drug-related arrests per 1000 adults 
  Correlation coefficient p-value 
% poverty 0.76 <.0001 
% public assistance 0.82 <.0001 
% low education 0.57 <.0001 
% unemployed 0.39 0.001 
% residential instability 0.16 0.195 
Neighborhood deprivation index 0.90 <.0001 







Figure C.1  Scatter plot of neighborhood deprivation index and drug-related arrests per 1000 adults in 
New York City community districts in 2010 (N=68).  Community districts with adult populations <100 are 













































Table C.3  Unadjusted and adjusted associations of the log of distance to the nearest syringe exchange program and drug-related arrests per 1000 adults with high-risk 
injection behavior among PHARM-Link study participants (N=484) 
  Receptive syringe sharing Use of unsafe syringe source Unsterile syringe use 
  












Log of distance to the nearest SEP 1.02 (0.86, 1.20) 0.95 (0.80, 1.14) 1.00 (0.87, 1.16) 1.04 (0.88, 1.22) 0.99 (0.90, 1.09) 0.96 (0.87, 1.06) 
Drug-related arrests per 1000 adults 0.97 (0.88, 1.08) 1.12 (0.97, 1.29) 1.00 (0.92, 1.09) 1.04 (0.92, 1.19) 1.00 (0.94, 1.05) 1.06 (0.98, 1.15) 
Note: Values shown are risk ratios and 95% confidence intervals for 1-unit increases in log of distance to the nearest SEP and 10-unit increases in drug-related arrests per 
1000 adults.  Adjusted models were controlled for neighborhood deprivation index and the following individual-level confounders: age, gender, race, education, income, 
homelessness, sexual orientation, and injection frequency. 
 
